[{"text": "Premium Cyclacel Pharmaceuticals Says David Lazar Buys $3.1 Million in Preferred Stock, Becomes Interim CEO MT Newswires Fri, Jan 3, 2025, 6:49 PM 1 min read In this article: CYCC +4.50% Cyclacel Pharmaceuticals (CYCC) said investor David Lazar agreed to buy $3.1 million in preferred st Premium Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in Terms and Privacy Policy Privacy Dashboard Recommended stories", "symbol": "CYCC", "date": "2025-01-03T18:49:39", "sentiment": {"score": 0.03322118800133467, "confidence": 0.047931745648384094, "probabilities": {"positive": 0.047931745648384094, "negative": 0.014710557647049427, "neutral": 0.9373576641082764}}, "embedding": [-0.005570445209741592, -0.11555318534374237, -0.01828235201537609, 0.030112670734524727, -0.06778063625097275, 0.06552103161811829, 0.05124914273619652, 0.22138811647891998, 0.10284972190856934, 0.01900229975581169, 0.028613584116101265, 0.2288760393857956, 0.03875023126602173, -0.013921931385993958, 0.05716537684202194, 0.03316226974129677, 0.12183353304862976, 0.021823173388838768, 0.05488348379731178, 0.01785031333565712, -0.1770993322134018, -0.1393785923719406, -0.0383288599550724, 0.023576073348522186, 0.08643842488527298, 0.07612799853086472, -0.18745234608650208, 0.15501435101032257, 0.04767793044447899, -0.04710668697953224, -0.0029467795975506306, -0.013858760707080364, 0.2142879068851471, -0.10595827549695969, 0.0063341218046844006, -0.06778059154748917, -0.16338922083377838, -0.04283389076590538, -0.09437938034534454, 0.014756874181330204, 0.12475530058145523, -0.11039039492607117, -0.19582781195640564, 0.04782608523964882, -0.05829915776848793, 0.005251714028418064, -0.058563634753227234, 0.0924563780426979, 0.1011745035648346, -0.018899228423833847, -0.038473304361104965, -0.11652732640504837, 0.03697124868631363, -0.12105301022529602, -0.07380127161741257, 0.09327332675457001, -0.23545391857624054, -0.04644419625401497, 0.07802566885948181, -0.11490209400653839, -0.018998080864548683, -0.045016609132289886, -0.1032743901014328, 0.06990909576416016, -0.017141826450824738, 0.10030276328325272, 0.00871287565678358, 0.007208534982055426, -0.010559952817857265, 0.019244350492954254, -0.006583790294826031, 0.06902705878019333, 0.07001462578773499, 0.008997942321002483, -0.02867497317492962, 0.06660105288028717, 0.20564667880535126, -0.07765976339578629, -0.13522109389305115, -0.12088685482740402, 0.06810394674539566, 0.02981318160891533, -0.10052280873060226, -0.01920979470014572, -0.07983310520648956, 0.021944088861346245, 0.09227130562067032, 0.0671984925866127, 0.028102468699216843, -0.05577849969267845, 0.21836329996585846, -0.03148115053772926, -0.04730495810508728, -0.0642208680510521, -0.24553555250167847, 0.09228622168302536, -0.07968319952487946, -0.004411516711115837, -0.11758652329444885, 0.008716358803212643, 0.18105614185333252, 0.025928612798452377, -0.03900306299328804, -0.0012318433728069067, -0.01932288333773613, -0.1358722299337387, -0.046556081622838974, 0.15074422955513, 0.027377355843782425, 0.08433790504932404, -0.16334311664104462, -0.05412062257528305, -0.08016260713338852, -0.15236394107341766, -0.17160941660404205, 0.17218095064163208, -0.10810019075870514, -0.10253666341304779, 0.14131835103034973, -0.1838965117931366, 0.083558090031147, 0.015293288044631481, 0.010135526768863201, -0.012778650037944317, -0.06594731658697128, 0.07455708086490631, -0.10846127569675446, 1.4511323477267594e-32, -0.10045784711837769, 0.14919067919254303, 0.08453574776649475, -0.14936459064483643, -0.0735398605465889, 0.05167960375547409, 0.24055632948875427, -0.034395769238471985, -0.1738501489162445, -0.09614460170269012, -0.11724235117435455, 0.15707986056804657, 0.008754805661737919, 0.06337787955999374, -0.17099204659461975, -0.09280974417924881, -0.053283512592315674, 0.025321772322058678, 0.12775713205337524, -0.050243403762578964, 0.07898544520139694, 0.01577909290790558, -0.06417266279459, 0.07910815626382828, 0.03264861926436424, 0.03860551118850708, 0.04245631769299507, -0.024371417239308357, 0.2264038771390915, 0.0571206696331501, -0.19059136509895325, 0.17164553701877594, -0.03933405131101608, 0.06529273837804794, 0.14916151762008667, 0.027628658339381218, -0.11589068174362183, -0.07414654642343521, 0.13227106630802155, -0.0963858962059021, 0.028645193204283714, 0.021920185536146164, -0.025135409086942673, 0.010349429212510586, -0.10260949283838272, 0.021999971941113472, -0.12928451597690582, 0.047770220786333084, 0.1594800055027008, -0.21404200792312622, 0.06407726556062698, 0.06512174010276794, -0.2465096265077591, 0.15984298288822174, -0.16561387479305267, -0.06976889073848724, -0.08654489368200302, -0.0217201579362154, 0.04889759421348572, -0.0220341756939888, 0.16279935836791992, 0.1946345716714859, 0.06550673395395279, 0.06998978555202484, -0.15028120577335358, 0.08021344244480133, -0.10198644548654556, -0.061078064143657684, -0.14547495543956757, 0.132563054561615, 0.11314563453197479, -0.07036083191633224, 0.06098966673016548, -0.036773599684238434, -0.004304187372326851, -0.06407000124454498, -0.08931587636470795, 0.10411699116230011, 0.2501407861709595, 0.1696268618106842, 0.011686800047755241, -0.10021497309207916, 0.10314459353685379, 0.07950865477323532, 0.0012258311035111547, 0.0006306786090135574, 0.04816746339201927, 0.04815062880516052, 0.07278094440698624, 0.07777950167655945, 0.08497960865497589, -0.11457725614309311, 8.858564251568168e-05, 0.18584908545017242, -0.12386929243803024, -1.6486643286172567e-32, -0.07931498438119888, -0.03888740763068199, 0.13051174581050873, 0.022631898522377014, -0.07552909106016159, -0.013049749657511711, -0.15985114872455597, 0.052611690014600754, 0.1642187535762787, 0.07870309799909592, 0.1575005054473877, 0.13986244797706604, -0.01972072385251522, 0.03873058781027794, 0.03511987626552582, -0.04741798713803291, 0.054794248193502426, -0.15179505944252014, -0.06635943055152893, -0.005237458273768425, 0.027820918709039688, 0.0519242063164711, -0.08051244914531708, 0.3413068354129791, 0.06509465724229813, -0.10146595537662506, 0.1764461249113083, 0.12452423572540283, -0.03158805891871452, -0.022915689274668694, -0.14711031317710876, -0.03790026158094406, -0.23799636960029602, -0.006253604777157307, 0.01693066582083702, 0.08385030180215836, 0.023878153413534164, 0.05454802140593529, 0.03313830494880676, 0.08097333461046219, 0.09973134100437164, -0.11180339008569717, 0.10544399917125702, 0.0030293066520243883, 0.1464201658964157, 0.028380803763866425, -0.002714581787586212, -0.13724303245544434, 0.13455374538898468, -0.007812716998159885, -0.04822753369808197, 0.05614669620990753, 0.022616825997829437, 0.13031254708766937, -0.14513042569160461, 0.16663770377635956, 0.04045533016324043, 0.008215806446969509, 0.1671048104763031, -0.056965138763189316, 0.09713461250066757, 0.10508071631193161, -0.18075509369373322, -0.15216517448425293, -0.03153423219919205, 0.02816902846097946, 0.05571773275732994, -0.17801909148693085, 0.014608063735067844, -0.17769649624824524, 0.019422808662056923, -0.12432966381311417, -0.09389306604862213, -0.2798081934452057, -0.05359472706913948, 0.1652609258890152, -0.0994962528347969, 0.05929785594344139, -0.016316812485456467, 0.021099114790558815, 0.09156373888254166, 0.029267407953739166, 0.11425594240427017, 0.024506598711013794, -0.07671228796243668, -0.05258394405245781, 0.06449554860591888, -0.12167076021432877, -0.19266323745250702, -0.013994179666042328, -0.06974451243877411, -0.12646639347076416, -0.06772766262292862, 0.08940786868333817, 0.011941281147301197, -1.0018248275400765e-07, 0.018891973420977592, -0.13543155789375305, 0.06362184137105942, 0.0417436808347702, 0.21934184432029724, -0.06201384216547012, -0.023839838802814484, -0.06358923017978668, -0.05503586307168007, 0.2098889946937561, -0.012488403357565403, -0.03059631772339344, -0.06448476761579514, -0.08411367237567902, -0.04432354494929314, -0.007802027277648449, -0.025866813957691193, 0.043553873896598816, -0.021763106808066368, -0.06179232522845268, -0.026461105793714523, 0.13605499267578125, 0.08038400113582611, -0.08980973064899445, 0.04893975704908371, -0.00983897503465414, 0.10259988158941269, -0.021484438329935074, 0.09799434244632721, 0.09815642982721329, 0.014824985526502132, -0.0691695436835289, -0.050891973078250885, 0.03368537500500679, 0.07206394523382187, -0.044678688049316406, 0.03667394816875458, 0.0032674684189260006, 0.014442380517721176, -0.07932277768850327, -0.0046461704187095165, -0.06635265797376633, 0.004915730096399784, 0.06227927282452583, -0.1580042839050293, -0.007044647820293903, -0.20649848878383636, -0.29095324873924255, 0.11701690405607224, -0.1458226591348648, 0.1526588648557663, -0.023839958012104034, 0.06604978442192078, 0.025856271386146545, 0.10058260709047318, -0.13551531732082367, -0.07247795164585114, -0.09363766014575958, -0.1593853235244751, -0.03953029215335846, -0.08663469552993774, -0.23413719236850739, 0.09606698155403137, 0.13941779732704163], "changes": {"1wk": -8.69565668088043, "1mo": -28.260868015947356}}, {"text": "Cyclacel Pharmaceuticals Announces Agreement for the Acquisition of Preferred Stock by David Lazar Cyclacel Fri, Jan 3, 2025, 5:01 PM 7 min read In This Article: CYCC +4.50% CYCCP -8.24% Cyclacel David Lazar agrees to invest $3.1 million in Preferred Stock\u00a0and becomes Interim CEO BERKELEY HEIGHTS, N.J., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; \"Cyclacel\" or the \"Company\") today announced that the Company entered into a securities purchase agreement (\u201cAgreement\u201d) with investor David Lazar (\u201cLazar\u201d), pursuant to which he agreed to purchase from the Company 1,000,000 shares of Series C Convertible Preferred Stock (the \u201cC Preferred Stock\u201d) and 2,100,000 shares of Series D Convertible Preferred Stock (the \u201cD Preferred Stock\u201d) of Cyclacel at a purchase price of $1.00 per share for aggregate gross proceeds of $3.1 million, subject to the terms and conditions of the Agreement. The proceeds of the transaction will be used to settle outstanding liabilities of the Company and other general corporate and operating purposes. Lazar is purchasing 1,000,000 shares of C Preferred Stock for $1,000,000 at an initial closing to occur on or about January 3, 2025. Each share of C Preferred Stock is convertible into 2.65 shares of Company common stock. The aggregate number of shares of common stock issuable upon conversion of the C Preferred Stock is subject to a 5% beneficial ownership limitation prior to stockholder approval of the transaction. Subject to the satisfaction of certain closing conditions and within two business days of the date that the Company\u2019s stockholders approve the issuance of all the shares of Common Stock upon conversion of the C Preferred Stock and D Preferred Stock, as required by the applicable rules and regulations of the Nasdaq Stock Market (the \u201cPreferred Stock Stockholder Approval\u201d), Lazar will pay an additional $2,100,000 in exchange for 2,100,000 shares of D Preferred Stock at a second closing. Each share of D Preferred Stock shall be convertible into 110 shares of common stock. In connection with the Agreement, the Company\u2019s Board of Directors will be reconstituted. Dr. Samuel Barker will continue to serve as Chairman, and Paul McBarron and Spiro Rombotis will continue as directors. David Natan, a seasoned financial executive with biopharmaceutical industry experience, will join the Board and will chair the audit committee. In addition, Spiro Rombotis stepped down from his position as Chief Executive Officer of the Company and David Lazar was appointed as interim Chief Executive Officer. Dr. Kenneth Ferguson, Dr. Christopher Henney, Dr.\u00a0Brian Schwartz, Dr. Robert Spiegel and Ms. Karin Walker have resigned from the Board. The Company wishes to express its gratitude to the departing directors for their long and dedicated service and their support of Cyclacel\u2019s efforts to serve the unmet medical needs of cancer patients. Story Continues On January 2, 2025, the Company also entered into a Warrant Exchange Agreement (the \u201cExchange Agreement\u201d) with the holder (the \u201cHolder\u201d) of certain existing warrants (the \u201cExchanged Warrants\u201d) to purchase an aggregate of 24,844,725 shares of the Company\u2019s common stock. Pursuant to the Exchange Agreement, on the closing date and subject to the receipt of approval of the Company\u2019s stockholders as required by the applicable rules and regulations of the Nasdaq Stock Market with respect to the issuance of all of the shares of common stock to be issued pursuant to the Exchange Agreement (the \u201cWarrant Exchange Stockholder Approval\u201d), the Company agreed to exchange with the Holder the Exchanged Warrants for an aggregate of 24,844,725 shares of Common Stock (the \u201cNew Shares\u201d) and $1,100,000 in cash (collectively, the \u201cExchange\u201d). To the extent the Holder would otherwise beneficially own in excess of any beneficial ownership limitation applicable to the Holder after giving effect to the Exchange, the Exchanged Warrants shall be exchanged for a number of New Shares issuable to the Holder without violating the beneficial ownership limitation and the remainder of the Holder\u2019s Exchanged Warrants shall be issued as pre-funded warrants to purchase the number of shares of Common Stock equal to the number of shares of Common Stock in excess of the beneficial ownership limitation. The closing of the Exchange is expected to take place substantially concurrently with the date on which the Warrant Exchange Stockholder Approval is received, subject to the receipt by the Company of the Preferred Stock Stockholder Approval. The Company also agreed to register the New Shares for resale pursuant to certain registration rights set forth in the Exchange Agreement. The Board has directed management to reduce operating costs while strategic alternatives are being explored. There can be no assurance that the exploration of strategic alternatives will result in any agreement or transaction, or as to the timing of any such agreement or transaction. Further, there can be no assurance that the Company will receive the Preferred Stock Stockholder Approval or the Warrant Exchange Stockholder Approval. The Company has received a written communication from the Nasdaq Stock Market, and expects to receive formal notification, that, in response to the Company\u2019s request for an extension, the new deadline to demonstrate compliance with Nasdaq\u2019s minimum stockholders\u2019 equity requirement is February 6, 2025. If the Company fails to regain compliance during the required compliance period, its securities would be subject to delisting. About Cyclacel Pharmaceuticals, Inc. Cyclacel is a clinical-stage, biopharmaceutical company developing innovative cancer medicines based on cell cycle, transcriptional regulation and mitosis biology. The transcriptional regulation program is evaluating fadraciclib, a CDK2/9 inhibitor, currently in Phase 2 clinical trials, and the anti-mitotic program plogosertib, a PLK1 inhibitor, currently in Phase 1 clinical trials, in patients with both solid tumors and hematological malignancies. For additional information, please visit www.cyclacel.com. Forward-looking Statements This news release contains certain forward-looking statements that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. Such forward-looking statements include, among other things, statements related to the receipt of stockholder approvals to issue the shares of common stock pursuant to the contemplated transactions, the consummation of a second closing pursuant to the Agreement, the Company\u2019s exploration and review of strategic alternatives, its ability to identify and complete a transaction as a result of the strategic review process, its plans to reduce costs and conserve cash and Cyclacel\u2019s ability to regain and maintain compliance with Nasdaq\u2019s continued listing requirements. You are urged to consider statements that include the words \"may,\" \"will,\" \"would,\" \"could,\" \"should,\" \"believes,\" \"estimates,\" \"projects,\" \"potential,\" \"expects,\" \"plans,\" \"anticipates,\" \"intends,\" \"continues,\" \"forecast,\" \"designed,\" \"goal,\" or the negative of those words or other comparable words to be uncertain and forward-looking. These risks and uncertainties include the risk that the Company may not be successful in receiving the stockholder approvals contemplated and may not consummate a second closing pursuant to the Agreement, the uncertainty of whether the Company is able to regain and maintain compliance with Nasdaq\u2019s continued listing requirements, the uncertainty of pursuing strategic alternatives and consummating one or more strategic transactions on attractive terms, if at all; the Company\u2019s actual reductions in spending as compared to anticipated cost reductions; the Company\u2019s costs of continuing to operate as a public company; and the other risks described more fully in Cyclacel Pharmaceuticals\u2019 filings with the Securities and Exchange Commission, including the \u201cRisk Factors\u201d section of the Company\u2019s Annual Report on Form 10-K for the year ending December 31, 2023 and its other documents subsequently filed with or furnished to the Securities and Exchange Commission, including its Form 10-Q for the quarter ended September 30, 2024. For a further list and description of the risks and uncertainties the Company faces, please refer to our most recent Annual Report on Form 10-K and other periodic filings we file with the\u00a0Securities and Exchange Commission\u00a0that are available at www.sec.gov . Such forward-looking statements are current only as of the date they are made, and we assume no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. Contacts Company: Paul McBarron, (908) 517-7330, IR@cyclacel.com \u00a9 Copyright 2025 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. The Cyclacel logo and Cyclacel\u00ae are trademarks of Cyclacel Pharmaceuticals, Inc. View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CYCC", "date": "2025-01-03T17:01:00", "sentiment": {"score": 0.011332917958498001, "confidence": 0.029790526255965233, "probabilities": {"positive": 0.029790526255965233, "negative": 0.018457608297467232, "neutral": 0.9517518877983093}}, "embedding": [-0.04007178172469139, -0.014600235968828201, 0.001318732276558876, -0.12154591083526611, -0.2746577858924866, 0.0813283771276474, 0.04413772001862526, 0.22205579280853271, 0.17901785671710968, 0.06714717298746109, -0.010916044935584068, 0.07926218211650848, 0.06265819072723389, -0.01817450486123562, -0.09510010480880737, 0.061137668788433075, 0.04137778654694557, 0.09314946830272675, -0.1977749913930893, 0.14229726791381836, -0.17356064915657043, -0.17727872729301453, -0.05118279159069061, -0.02420363947749138, 0.0131618557497859, -0.007592691108584404, -0.07000722736120224, 0.11654435843229294, -0.030649589374661446, -0.11034718155860901, 0.06640681624412537, 0.10971963405609131, 0.13847492635250092, -0.10364173352718353, -0.02854284644126892, -0.010672835633158684, -0.20563223958015442, 0.0039008641615509987, 0.05166512355208397, -0.04011724144220352, 0.0004871925339102745, 0.02329983189702034, -0.11330723762512207, 0.08218860626220703, 0.017511717975139618, 0.029660778120160103, -0.07916808128356934, 0.08112352341413498, 0.11336145550012589, -0.026081494987010956, -0.04828302562236786, -0.07067010551691055, -0.026049654930830002, 0.04317701607942581, -0.13441109657287598, 0.12712672352790833, -0.18445904552936554, -0.07291276752948761, 0.06813426315784454, -0.011680955067276955, -0.013053374364972115, 0.051523953676223755, -0.019316982477903366, 0.030513113364577293, 0.11610107123851776, 0.00929985661059618, -0.0012651733122766018, -0.012353731319308281, -0.0398498997092247, 0.10923594236373901, 0.07281913608312607, -0.008865409530699253, -0.060122501105070114, -0.022594917565584183, -0.15840859711170197, 0.027077123522758484, 0.07969202846288681, 0.025666216388344765, -0.02853216789662838, -0.2027837634086609, 0.03267957270145416, 0.13288117945194244, -0.09643556922674179, -0.1741022765636444, -0.06333120167255402, -0.05652101710438728, 0.10679101943969727, 0.19451837241649628, 0.11189164966344833, 0.001404061447829008, 0.08402156084775925, 0.029802445322275162, 0.02546117827296257, -0.18498094379901886, -0.050301022827625275, 0.01702200062572956, 0.018623383715748787, 0.05022091418504715, 0.02070552110671997, 0.07946676015853882, 0.22684037685394287, 0.06724891811609268, -0.1058414876461029, -0.09192107617855072, -0.1276860535144806, -0.07393711805343628, -0.023804519325494766, -0.03652592748403549, -0.05737621337175369, -0.00187746062874794, -0.23985517024993896, -0.0058685727417469025, -0.15535205602645874, -0.06642208248376846, -0.2196483314037323, 0.1586201786994934, 0.037169747054576874, -0.051968883723020554, 0.2000051736831665, -0.27103087306022644, 0.09821726381778717, -0.042931634932756424, 0.047094933688640594, -0.024687856435775757, -0.06729201972484589, -0.025274233892560005, -0.15565605461597443, 7.49375958876079e-33, -0.11240323632955551, 0.009314239956438541, -0.028814449906349182, -0.02127797342836857, -0.048658572137355804, 0.04028689116239548, 0.17164556682109833, 0.009898858144879341, -0.22643129527568817, -0.05746211111545563, -0.12715572118759155, 0.022498546168208122, 0.03472289815545082, -0.07424762099981308, -0.09564995765686035, -0.06633345037698746, -0.028738416731357574, 0.030305881053209305, 0.07277476787567139, -0.06349780410528183, 0.08863517642021179, 0.11867962032556534, -0.051263585686683655, 0.17605546116828918, 0.041948989033699036, -0.015775436535477638, -0.06440772861242294, -0.004217813257128, 0.04737294465303421, 0.011939560063183308, 0.032508671283721924, 0.045529793947935104, -0.0908682644367218, 0.024556558579206467, 0.08136645704507828, -0.04166308045387268, -0.06632481515407562, -0.04165421426296234, 0.18231454491615295, -0.034324176609516144, 0.008830852806568146, 0.009606897830963135, -0.009759974665939808, -0.07941045612096786, -0.12016260623931885, 0.05459019914269447, -0.052499428391456604, 0.1446928083896637, 0.018024755641818047, -0.03717757761478424, 0.052507609128952026, 0.010183513164520264, -0.14692945778369904, 0.010319942608475685, -0.10899919271469116, -0.03929038718342781, -0.13119074702262878, -0.05203896015882492, -0.013267364352941513, 0.18475112318992615, 0.0027110613882541656, 0.2127877175807953, -0.005558197386562824, 0.09873528778553009, -0.14940977096557617, 0.0975196436047554, -0.11487536132335663, -0.0483931228518486, -0.011785568669438362, 0.03431970998644829, -0.019595395773649216, -0.03288644552230835, 0.16449445486068726, -0.04841787368059158, 0.04078716039657593, -0.10472308099269867, 0.009591455571353436, 0.1168631762266159, 0.12483303993940353, 0.0621253103017807, -0.06437419354915619, -0.030002493411302567, -0.017087580636143684, 0.11399590969085693, -0.007534032687544823, -0.02906322106719017, 0.006443545687943697, -0.016032768413424492, -0.05445444583892822, 0.06104249507188797, 0.04770367965102196, -0.18201561272144318, 0.06826069951057434, 0.18380030989646912, 0.048736851662397385, -8.985390655609254e-33, -0.010176287963986397, -0.08881504833698273, 0.04364839196205139, -0.010600856505334377, -0.03482653573155403, -0.013118937611579895, 0.06970137357711792, -0.20800378918647766, 0.039596401154994965, -0.05694987624883652, 0.019825542345643044, 0.10497850179672241, 0.06431058049201965, -0.003721710992977023, -0.1420990377664566, -0.036287564784288406, 0.033860038965940475, -0.023500772193074226, 0.004202481359243393, 0.009472357109189034, 0.014260435476899147, 0.10799219459295273, 0.07975456118583679, 0.2737767994403839, 0.11816437542438507, 0.06541826575994492, 0.1161106675863266, 0.16308589279651642, 0.08964932709932327, 0.03974197804927826, -0.0785219669342041, -0.09225418418645859, -0.21372577548027039, 0.01351542491465807, 0.028318775817751884, -0.09690374881029129, 0.07176265120506287, -0.04929211735725403, 0.06101011484861374, 0.0748395174741745, 0.08725034445524216, -0.022693675011396408, 0.06946095079183578, 0.07811573147773743, 0.14768162369728088, -0.031101999804377556, 0.020926857367157936, -0.1906258761882782, 0.18082433938980103, 0.0036674169823527336, 0.03509817272424698, 0.0623256079852581, 0.031291525810956955, 0.11598655581474304, -0.07472620904445648, 0.24618594348430634, 0.10399849712848663, 0.006431703455746174, 0.15394988656044006, -0.04009450227022171, 0.10142816603183746, 0.0593770295381546, 0.0031279362738132477, -0.06506674736738205, 0.07059997320175171, -0.04124798625707626, -0.05476323515176773, -0.014192160218954086, -0.02649872377514839, -0.11035173386335373, -0.0014823037199676037, -0.18069705367088318, 0.10210040211677551, -0.20170894265174866, 0.09623989462852478, 0.08806845545768738, 0.07915353775024414, -0.1233234703540802, -0.00022264663130044937, 0.04923035576939583, -0.08609050512313843, 0.11084544658660889, 0.10188376903533936, 0.11035748571157455, -0.0601985938847065, -0.01644168049097061, 0.03239469602704048, -0.040758635848760605, -0.05411989241838455, -0.05428731068968773, -0.028786927461624146, -0.036770060658454895, 0.1343860775232315, 0.04913203790783882, -0.04054327309131622, -1.0012833229211537e-07, -0.019475646317005157, -0.144576758146286, 0.030301369726657867, 0.006447775289416313, 0.21272221207618713, -0.10669936239719391, -0.02513786405324936, -0.10570964217185974, -0.06814570724964142, 0.07932719588279724, 0.047834090888500214, 0.13128387928009033, -0.18255525827407837, -0.01868053525686264, -0.13867950439453125, 0.028788795694708824, -0.10979266464710236, -0.05090685933828354, -0.08488607406616211, -0.04684627801179886, -0.10665205121040344, 0.05067472159862518, -0.004588081501424313, -0.04844433069229126, 0.00290664192289114, -0.07448824495077133, 0.13013292849063873, -0.021166115999221802, 0.03168562799692154, 0.042093995958566666, 0.02210845798254013, 0.0010125383269041777, 0.05940840393304825, 0.04680115729570389, 0.06458723545074463, -0.06703173369169235, 0.06235280632972717, 0.11081129312515259, 0.02843204140663147, 0.03037896938621998, -0.045216962695121765, 0.004489502869546413, -0.011543290689587593, 0.06414994597434998, -0.013048753142356873, -0.08260801434516907, -0.28747206926345825, -0.10009346902370453, 0.05863484740257263, -0.15732435882091522, 0.14587748050689697, 0.013013810850679874, -0.02727922983467579, 0.07127602398395538, 0.13816189765930176, -0.014887386001646519, -0.12830060720443726, -0.047921400517225266, -0.0034806434996426105, -0.06565138697624207, -0.08386130630970001, -0.085019052028656, 0.025618772953748703, 0.06398646533489227], "changes": {"1wk": -10.869567611717729, "1mo": -28.260868015947356}}, {"text": "PREMIUM Sector Update: Health Care Stocks Rise in Late Afternoon Trading MT Newswires Fri, Jan 3, 2025, 11:58 PM 1 min read In This Article: NMRA -3.63% Health care stocks advanced late Friday afternoon with the NYSE Health Care Index and the Health Car PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CYCC", "date": "2025-01-03T23:58:03", "sentiment": {"score": 0.10776159632951021, "confidence": 0.11906591057777405, "probabilities": {"positive": 0.11906591057777405, "negative": 0.011304314248263836, "neutral": 0.8696298003196716}}, "embedding": [-0.10653567314147949, -0.1051052063703537, 0.0065160649828612804, 0.15516477823257446, 0.1325748711824417, -0.02481747977435589, -0.09795523434877396, -0.04776972904801369, -0.019047828391194344, -0.036961570382118225, -0.02243649587035179, 0.20044240355491638, -0.07282539457082748, -0.032228704541921616, 0.09519834071397781, -0.04540097713470459, 0.0065766507759690285, -0.08320476114749908, -0.08316221833229065, 0.17133405804634094, -0.1587042510509491, 0.015436510555446148, 0.13681916892528534, 0.021338069811463356, 0.09871471673250198, 0.032328423112630844, -0.10149523615837097, -0.059325091540813446, -0.012557017616927624, 0.00686471164226532, -0.008199677802622318, 0.014557555317878723, 0.05831720679998398, 0.0031984245870262384, -0.06850806623697281, -0.12189505249261856, 0.09282851964235306, 0.04768082872033119, -0.06446711719036102, 0.04618271440267563, 0.15005281567573547, -0.1912882775068283, -0.13151638209819794, 0.12487321346998215, 0.06639038026332855, -0.05475451052188873, -0.07031022012233734, 0.004143748432397842, 0.1694522500038147, -0.005993344355374575, -0.1781083345413208, -0.2181674689054489, 0.012000031769275665, -0.019812822341918945, -0.06488775461912155, -0.056737784296274185, -0.14804497361183167, -0.19128042459487915, 0.0044631860218942165, -0.04956617206335068, -0.006688060238957405, -0.02238238789141178, 0.07646585255861282, 0.11952701956033707, 0.024708280339837074, -0.0011573855299502611, 0.058163415640592575, 0.13060542941093445, -0.05339445173740387, -0.1669982373714447, 0.045389335602521896, -0.07473535090684891, 0.08934376388788223, 0.040362682193517685, -0.012063748203217983, 0.16874350607395172, 0.18165430426597595, -0.039506085216999054, 0.17969495058059692, -0.1537359356880188, -7.363620534306392e-05, -0.04436184838414192, 0.05603828653693199, 0.09277068078517914, 0.035874612629413605, -0.006276944186538458, -0.10012681037187576, -0.04835743457078934, -0.08548328280448914, -0.1767280399799347, 0.06087283045053482, -0.03997024893760681, -0.08307528495788574, 0.06227318197488785, 0.0591566376388073, -0.019478539004921913, -0.20373958349227905, -0.16059915721416473, -0.1185402125120163, 0.061062008142471313, 0.10249999910593033, 0.0694793313741684, -0.0023800083436071873, 0.19011682271957397, -0.14047910273075104, -0.1427551805973053, -0.05986037105321884, 0.13241824507713318, -0.017179924994707108, 0.18988849222660065, -0.007118928246200085, 0.1664818823337555, 0.03443890064954758, -0.14001017808914185, -0.18218940496444702, 0.18489082157611847, -0.07060594111680984, -0.049785494804382324, 0.05362008512020111, 0.057732727378606796, 0.02523072250187397, 0.07148028910160065, -0.20591172575950623, -0.07981675118207932, 0.09997379034757614, 0.13400252163410187, -0.022299930453300476, 1.0350670773423708e-32, 0.015182954259216785, 0.07868989557027817, 0.12499961256980896, -0.04965737462043762, -0.012124461121857166, -0.052633628249168396, 0.1170903891324997, -0.22162850201129913, -0.010042063891887665, -0.061715949326753616, -0.2508736252784729, 0.2533828318119049, -0.022297291085124016, -0.035062480717897415, -0.23990106582641602, -0.24888132512569427, -0.09442289173603058, 0.07323337346315384, -0.007811175659298897, 0.028418809175491333, -0.04586498811841011, -0.1007368341088295, -0.05100376158952713, -4.437948518898338e-05, -0.06144091114401817, 0.06672418117523193, -0.006830854341387749, -0.11114820092916489, 0.08774712681770325, 0.10018479079008102, -0.03696000948548317, 0.07750571519136429, -0.06073327735066414, -0.1759684979915619, 0.048347413539886475, 0.07083655893802643, -0.0848122239112854, -0.01202454511076212, 0.01179623045027256, -0.16411349177360535, -0.06514418125152588, -0.06261039525270462, -0.09992911666631699, -0.04902932792901993, -0.045944664627313614, 0.10467095673084259, -0.012170059606432915, -0.11490840464830399, 0.05228326842188835, -0.1090562641620636, -0.11046475917100906, 0.05908801406621933, -0.2331261932849884, -0.07457240670919418, -0.05691281706094742, -0.01942368783056736, 0.02436159923672676, -0.05540073290467262, -0.007921389304101467, -0.028857240453362465, 0.09865204244852066, 0.09661378711462021, 0.07595381885766983, -0.08090318739414215, -0.19718101620674133, 0.10183079540729523, -0.12697456777095795, 0.061165302991867065, -0.07263318449258804, 0.3099924921989441, 0.2087205946445465, 0.07689138501882553, -0.037070490419864655, -0.00430244579911232, -0.03686448931694031, 0.06133825331926346, -0.08025608956813812, -0.025670252740383148, 0.12883809208869934, 0.08010393381118774, 0.1736534833908081, -0.01135244034230709, 0.10300184786319733, 0.04099166765809059, 0.17781725525856018, 0.07152508944272995, 0.014001255854964256, -0.009300459176301956, -0.02853168174624443, -0.09727796167135239, -0.0715157613158226, 0.0773191973567009, 0.14566239714622498, 0.09003070741891861, -0.0560084730386734, -1.5699257497057458e-32, -0.0489792563021183, 0.08383471518754959, -0.08046049624681473, -0.08786015957593918, -0.0584232397377491, -0.09017878025770187, -0.07947175204753876, 0.08144477009773254, 0.11516435444355011, 0.14511843025684357, 0.07264924049377441, 0.04888936132192612, -0.041843608021736145, 0.03794553875923157, 0.05219446122646332, -0.045559488236904144, -0.050909802317619324, -0.11274626851081848, -0.0597064346075058, 0.09366132318973541, 0.01826108619570732, 0.02964838221669197, -0.10689449310302734, 0.3713652193546295, 0.13726000487804413, -0.01905404031276703, 0.0014007649151608348, 0.25355884432792664, 0.13479740917682648, -0.19716933369636536, -0.1749754548072815, -0.07931740581989288, -0.12418075650930405, -0.04343928024172783, 0.017467740923166275, -0.024383803829550743, 0.0793677493929863, -0.06586223840713501, -0.011500507593154907, -0.03385922312736511, 0.17785316705703735, -0.16470447182655334, 0.002881108084693551, 0.12036346644163132, 0.09921335428953171, 0.046780701726675034, 0.05777944251894951, 0.0714794248342514, 0.0885268896818161, -0.00315145798958838, 0.00935894064605236, 0.03213980793952942, 0.06864150613546371, 0.26809313893318176, -0.09510724246501923, 0.1580459326505661, -0.014888012781739235, -0.0064010717906057835, -0.16248996555805206, -0.07082335650920868, 0.052249301224946976, 0.1408637911081314, -0.2542714476585388, -0.1225321814417839, -0.037332043051719666, -0.06429209560155869, 0.15053166449069977, -0.13302263617515564, 0.0827825516462326, -0.026268569752573967, -0.029374858364462852, -0.04267863184213638, -0.17592261731624603, -0.3080956041812897, -0.028471937403082848, 0.04727024957537651, 0.006445402279496193, 0.0779271051287651, -0.06439752131700516, 0.07177329808473587, 0.09834539145231247, -0.043048858642578125, 0.0072294618003070354, -0.03980076685547829, -0.09119527786970139, 0.09521648287773132, 0.10269034653902054, -0.10908778756856918, -0.1489589512348175, 0.053194526582956314, -0.22872573137283325, -0.09783730655908585, -0.2560671269893646, 0.09146977216005325, -0.1836574375629425, -1.0056345445264014e-07, 0.12224046140909195, -0.07047885656356812, 0.022746121510863304, -0.0016015719156712294, 0.10858595371246338, -0.1105276420712471, -0.1271018087863922, 0.0025529719423502684, 0.07327780872583389, 0.23143956065177917, 0.1508110761642456, 0.1195182204246521, 0.023249603807926178, -0.18378621339797974, -0.033207494765520096, -0.055844709277153015, -0.1935035139322281, 0.16479258239269257, 0.04510374367237091, -0.155410498380661, 0.14152909815311432, 0.07364146411418915, 0.2100280374288559, -0.0013735851971432567, -0.016695460304617882, 0.09190564602613449, -0.10569274425506592, -0.049894340336322784, 0.11280098557472229, -0.004481240175664425, -0.024313053116202354, 0.045014072209596634, 0.1270851045846939, -0.08692571520805359, -0.01549957413226366, 0.007046982180327177, 0.14669419825077057, -0.017814310267567635, 0.08768722414970398, -0.05096542462706566, 0.07161012291908264, -0.046541135758161545, 0.017708301544189453, 0.02601560950279236, -0.11099867522716522, -0.03742757812142372, -0.10289191454648972, 0.005920981988310814, 0.14613303542137146, -0.2410646677017212, -0.00481002451851964, -0.15086357295513153, 0.13054578006267548, 0.10558545589447021, -0.07681968808174133, 0.08648750185966492, -0.12468133121728897, -0.09821078181266785, -0.22520363330841064, 0.15744996070861816, 0.10639327019453049, -0.3048274517059326, 0.05129410699009895, 0.17524614930152893], "changes": {"1wk": -8.69565668088043, "1mo": -28.260868015947356}}, {"text": "PREMIUM Sector Update: Health Care MT Newswires Fri, Jan 3, 2025, 9:42 PM Health care stocks rose Friday afternoon with the NYSE Health Care Index up 0.9% and the Health Care PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CYCC", "date": "2025-01-03T21:42:29", "sentiment": {"score": 0.3809386370703578, "confidence": 0.39370453357696533, "probabilities": {"positive": 0.39370453357696533, "negative": 0.012765896506607533, "neutral": 0.5935295224189758}}, "embedding": [-0.1260397732257843, -0.11101356893777847, 0.0880456417798996, 0.17157164216041565, 0.1825675517320633, -0.028292695060372353, -0.10412771254777908, -0.04179481044411659, -0.011988064274191856, -0.049365654587745667, -0.028041860088706017, 0.26153621077537537, -0.053625721484422684, -0.04317715764045715, 0.08256129920482635, -0.03589833527803421, 0.022056328132748604, -0.030199389904737473, -0.08684363216161728, 0.16430550813674927, -0.08021137118339539, -0.04040169715881348, 0.07845116406679153, 0.00910609308630228, 0.1516653299331665, 0.02474077232182026, -0.06204650178551674, -0.08933629095554352, -0.0410139225423336, 0.06966111809015274, -0.0053071617148816586, -0.1044091060757637, 0.07782530039548874, -0.02525724656879902, -0.11970537155866623, -0.082638218998909, 0.12263073772192001, 0.05401726812124252, -0.02033771015703678, 0.09730691462755203, 0.1310589462518692, -0.24152885377407074, -0.09929552674293518, 0.10591739416122437, 0.07070677727460861, 0.004124159459024668, -0.08636254072189331, 0.008495273068547249, 0.0875312015414238, 0.12461153417825699, -0.15075039863586426, -0.1915433257818222, 0.037449758499860764, -0.05885159596800804, -0.019520169124007225, -0.05585889518260956, -0.1731978803873062, -0.18882544338703156, 1.0754472896223888e-05, -0.0974755734205246, -0.06715979427099228, -0.03694257512688637, 0.04031097888946533, 0.13372811675071716, -0.00508353253826499, 0.10233279317617416, 0.1118152067065239, 0.16800379753112793, -0.020826654508709908, -0.24007365107536316, -0.015477748587727547, 6.223045056685805e-05, 0.09384838491678238, 0.021403968334197998, 0.05013125017285347, 0.19514426589012146, 0.1593170166015625, -0.006941105239093304, 0.1383444219827652, -0.14278706908226013, 0.07194783538579941, -0.08108523488044739, 0.0747542679309845, 0.11390482634305954, -0.019841624423861504, -0.04596641659736633, -0.07983706146478653, -0.0487932488322258, -0.081004299223423, -0.2846073508262634, 0.08388249576091766, -0.03299841657280922, -0.0295544620603323, 0.08825280517339706, 0.06314041465520859, -0.016086801886558533, -0.24903737008571625, -0.17175014317035675, -0.18082520365715027, 0.035219330340623856, -0.0005991580546833575, 0.02488231472671032, -0.03905085101723671, 0.1699114590883255, -0.049294620752334595, -0.21064485609531403, -0.15054987370967865, 0.11823520809412003, 0.07134461402893066, 0.08006894588470459, 0.04648376628756523, 0.11832326650619507, 0.06994446367025375, -0.16838368773460388, -0.1430089920759201, 0.0638357475399971, -0.12709872424602509, -0.09644947946071625, 0.08833455294370651, 0.06973244994878769, 0.05177979916334152, 0.1095837727189064, -0.21177808940410614, -0.03735024109482765, 0.02788524702191353, 0.04971408471465111, 0.013798662461340427, 9.91716608925571e-33, 0.03762742131948471, 0.11664058268070221, 0.18960359692573547, -0.1254425048828125, -0.02406458929181099, -0.05237239971756935, 0.11461794376373291, -0.1786864846944809, 0.005900121293962002, -0.03362486883997917, -0.2573675811290741, 0.2665570080280304, -0.020510897040367126, -0.029449157416820526, -0.2132071554660797, -0.3111841380596161, -0.02574562467634678, 0.12251964956521988, 0.10063230991363525, 0.09039372950792313, -0.0570327527821064, -0.09774421155452728, -0.08107355237007141, -0.0672992393374443, -0.1203969195485115, 0.06422095000743866, 0.059173353016376495, -0.10502747446298599, 0.09181436896324158, 0.10147534310817719, -0.11510633677244186, 0.0708213821053505, -0.04034822806715965, -0.1356731653213501, 0.0658981055021286, 0.09337981790304184, -0.11601914465427399, 0.04088284820318222, 0.025098826736211777, -0.20637130737304688, -0.1218348816037178, -0.09848905354738235, -0.12722571194171906, -0.06373852491378784, 0.005050810519605875, 0.08494185656309128, 0.005213103722780943, -0.1594749093055725, 0.07848770171403885, -0.16688355803489685, -0.08602218329906464, 0.12123820930719376, -0.2063741832971573, 0.01031921524554491, -0.03450436890125275, -0.045626040548086166, 0.02183643728494644, -0.0457778237760067, 0.024474039673805237, 0.015119034796953201, 0.19947023689746857, 0.11331726610660553, 0.06426239758729935, -0.12194366753101349, -0.23564714193344116, 0.09485718607902527, -0.05703369155526161, -0.001359865185804665, -0.07457118481397629, 0.2677386999130249, 0.2292262315750122, 0.07475560903549194, -0.061676137149333954, 0.0005693555576726794, -0.11920132488012314, 0.13946153223514557, -0.06142520532011986, 0.017278799787163734, 0.14906659722328186, 0.041949816048145294, 0.17484289407730103, -0.02782859094440937, 0.09954433143138885, 0.013097705319523811, 0.1748773753643036, 0.10864171385765076, 0.038363248109817505, 0.043785300105810165, -0.06772170215845108, -0.13114634156227112, -0.09774453938007355, 0.032255496829748154, 0.15150409936904907, 0.11505859345197678, -0.0268094465136528, -1.509673288828854e-32, -0.056020740419626236, 0.056188106536865234, -0.11193955689668655, -0.09580111503601074, -0.11577080935239792, -0.09259529411792755, 0.01640564575791359, 0.15188996493816376, 0.16609196364879608, 0.18714788556098938, 0.09248372912406921, 0.08923350274562836, -0.0572381429374218, 0.07127461582422256, 0.0372193418443203, 0.009166019968688488, -0.10120321810245514, -0.12007968872785568, -0.11615467816591263, 0.10144554823637009, -0.0030861860141158104, 0.10995017737150192, -0.14759282767772675, 0.3773559331893921, 0.09899678826332092, -0.005585311446338892, 0.09822209924459457, 0.23725172877311707, 0.17240890860557556, -0.18115876615047455, -0.1974545568227768, -0.10346611589193344, -0.10522054880857468, -0.04774780198931694, -0.044295668601989746, -0.07454591244459152, 0.1400166004896164, -0.032764535397291183, 0.012793595902621746, -0.008320892229676247, 0.18997475504875183, -0.18841847777366638, -0.0332324281334877, 0.07550365477800369, 0.12391550093889236, 0.06513302773237228, -0.004589847754687071, 0.10916633158922195, 0.1271994411945343, -0.0035701123997569084, -0.08381033688783646, 0.061356786638498306, 0.046066854149103165, 0.2279544174671173, -0.1706300675868988, 0.0881260558962822, -0.0719919502735138, 0.05196835845708847, -0.10999221354722977, -0.15641245245933533, -0.026848644018173218, 0.16066443920135498, -0.2704176604747772, -0.05738690495491028, -0.05477917194366455, -0.008959596045315266, 0.1391482651233673, -0.17862805724143982, 0.02465626411139965, -0.005865371320396662, -0.03440604731440544, -0.04892156273126602, -0.1836184412240982, -0.3873160481452942, 0.036392271518707275, 0.09399748593568802, 0.020030200481414795, 0.06572001427412033, -0.10804162174463272, 0.12761153280735016, 0.1574353277683258, -0.09658852219581604, 0.0016472721472382545, -0.021364957094192505, -0.11920779198408127, 0.051086314022541046, 0.19706033170223236, -0.17222726345062256, -0.23261071741580963, -0.007659319322556257, -0.23868654668331146, -0.15288008749485016, -0.28031617403030396, 0.09732116013765335, -0.047420062124729156, -1.004463712206416e-07, 0.1439288705587387, 0.008700855076313019, 0.03637556731700897, -0.008829997852444649, 0.1202397495508194, -0.09485841542482376, -0.12799912691116333, 0.009100810624659061, 0.062005601823329926, 0.23883606493473053, 0.07270009815692902, 0.06619670987129211, -0.03692066669464111, -0.13841062784194946, -0.01131146028637886, -0.09846297651529312, -0.17179588973522186, 0.12929333746433258, 0.06166963279247284, -0.13569368422031403, 0.12163339555263519, 0.07277638465166092, 0.2649487257003784, -0.04781823605298996, 0.009924602694809437, 0.07430153340101242, -0.05926145985722542, -0.09312858432531357, 0.0766107514500618, 0.0806228369474411, -0.005320997443050146, 0.037563905119895935, -0.01969030499458313, -0.0964646264910698, 0.017689280211925507, 0.0318494513630867, 0.05902358144521713, 0.016168493777513504, 0.12394586950540543, -0.03144366294145584, 0.06321129947900772, -0.07059507817029953, 0.07490763813257217, 0.09823057800531387, -0.08526409417390823, -0.05127805098891258, -0.06994862109422684, -0.04609611630439758, 0.17846935987472534, -0.23012377321720123, -0.015711894258856773, -0.12492574751377106, 0.09083129465579987, 0.019991165027022362, -0.05261585861444473, 0.08692596107721329, -0.1105014756321907, -0.11523602902889252, -0.23608557879924774, 0.2574313282966614, 0.1926082968711853, -0.2819761335849762, 0.009506882168352604, 0.12181739509105682], "changes": {"1wk": -8.69565668088043, "1mo": -28.260868015947356}}, {"text": "PREMIUM Sector Update: Health Care Stocks Higher Friday Afternoon MT Newswires Fri, Jan 3, 2025, 9:57 PM 1 min read In This Article: NMRA -3.63% Health care stocks rose Friday afternoon with the NYSE Health Care Index up 0.9% and the Health Care PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CYCC", "date": "2025-01-03T21:57:52", "sentiment": {"score": 0.15583210438489914, "confidence": 0.1671743541955948, "probabilities": {"positive": 0.1671743541955948, "negative": 0.011342249810695648, "neutral": 0.8214833736419678}}, "embedding": [-0.060604535043239594, -0.13837389647960663, -0.011837048456072807, 0.09953463077545166, 0.11158175021409988, -0.0494689978659153, -0.13281811773777008, -0.07407743483781815, -0.012823453173041344, -0.059569332748651505, -0.04884426295757294, 0.21730200946331024, -0.07809439301490784, -0.036056458950042725, 0.10733773559331894, -0.044611141085624695, 0.018310971558094025, -0.0671996995806694, -0.08696680516004562, 0.1288355439901352, -0.12779805064201355, -0.008904160000383854, 0.15429125726222992, -0.03237916901707649, 0.12119045108556747, 0.020628491416573524, -0.08604510128498077, -0.09479133784770966, -0.004004048649221659, 0.016842497512698174, 0.040861520916223526, 0.00779546145349741, 0.04397646337747574, -0.02086186781525612, -0.050806641578674316, -0.10838016867637634, 0.10188459604978561, 0.07529742270708084, -0.026172200217843056, 0.06793775409460068, 0.119424968957901, -0.15968090295791626, -0.14041516184806824, 0.12212932109832764, 0.03902113065123558, -0.0205229464918375, -0.09343399107456207, -0.02855348400771618, 0.14887495338916779, 0.03895077854394913, -0.16187699139118195, -0.22931265830993652, 0.0318705253303051, -0.01012786477804184, -0.037734828889369965, -0.04521852359175682, -0.12399843335151672, -0.21709242463111877, -0.014547070488333702, -0.05702200159430504, -0.033310580998659134, 0.00485237967222929, 0.0973038598895073, 0.12418393045663834, 0.029380127787590027, -0.02159636653959751, 0.06833112239837646, 0.09791959077119827, -0.05550394579768181, -0.17474637925624847, 0.021779831498861313, -0.0672202855348587, 0.09851261228322983, 0.017023637890815735, -0.02425866574048996, 0.1917373538017273, 0.15068013966083527, -0.013437759131193161, 0.1577158272266388, -0.10776934772729874, 0.03419496864080429, -0.08128208667039871, 0.04906495288014412, 0.14985492825508118, 0.021289799362421036, -0.04068860411643982, -0.1173693910241127, -0.07660502195358276, -0.08783035725355148, -0.18065746128559113, 0.08099573105573654, 0.03349004685878754, -0.056837331503629684, 0.03456468880176544, 0.051652420312166214, -0.029585476964712143, -0.21325376629829407, -0.13434703648090363, -0.16442885994911194, 0.07047434896230698, 0.05744897574186325, 0.031878601759672165, -0.024950295686721802, 0.14637188613414764, -0.12388640642166138, -0.13579344749450684, -0.05887160450220108, 0.10048941522836685, 0.005307145416736603, 0.17905086278915405, 0.008549896068871021, 0.15578247606754303, 0.029523223638534546, -0.13891497254371643, -0.16488714516162872, 0.12733231484889984, -0.0306682251393795, -0.03434178605675697, 0.08562072366476059, 0.03642033413052559, 0.03978704661130905, 0.08939722180366516, -0.17659388482570648, -0.046223703771829605, 0.06416302174329758, 0.12065601348876953, -0.038625553250312805, 1.1361373305888188e-32, 0.04203438386321068, 0.10295405983924866, 0.1638154685497284, -0.12145627290010452, -0.0023419319186359644, -0.03439793363213539, 0.12593454122543335, -0.22013115882873535, 0.011729101650416851, -0.05558081343770027, -0.2892923653125763, 0.23592448234558105, 0.012618448585271835, -0.039401788264513016, -0.21275848150253296, -0.26352405548095703, -0.10513123869895935, 0.09877456724643707, -0.017761779949069023, 0.05108488351106644, -0.036539386957883835, -0.08061273396015167, -0.04086973890662193, -0.006998133379966021, -0.0460968017578125, 0.007950916886329651, 0.014682266861200333, -0.1250959038734436, 0.063138946890831, 0.057026952505111694, -0.03062908723950386, 0.06501813232898712, -0.0072298296727240086, -0.13509978353977203, 0.05233020707964897, 0.06648097187280655, -0.04228507727384567, 0.023180343210697174, 0.004027398768812418, -0.18137188255786896, -0.07960687577724457, -0.05539543181657791, -0.04314804449677467, -0.05525898188352585, -3.712026955327019e-05, 0.09802962839603424, -0.03108922392129898, -0.1020442321896553, 0.05679421126842499, -0.14922676980495453, -0.11842218786478043, 0.06191311776638031, -0.24251596629619598, -0.040190763771533966, -0.032951027154922485, -0.06292840093374252, 0.051676198840141296, -0.03416294604539871, 0.04033955931663513, -0.011332019232213497, 0.07494837045669556, 0.07102864980697632, 0.057730529457330704, -0.05406727269291878, -0.17936460673809052, 0.08661028742790222, -0.0875961109995842, 0.06688861548900604, -0.026979152113199234, 0.30132144689559937, 0.17145641148090363, 0.08900043368339539, -0.04430790990591049, -0.025274675339460373, -0.055892739444971085, 0.042739707976579666, -0.09678180515766144, 0.01587708108127117, 0.14527907967567444, 0.07207909226417542, 0.1890871673822403, -0.006974918767809868, 0.09042970091104507, 0.03694484382867813, 0.1841353327035904, 0.09313980489969254, 0.022761961445212364, 0.055235493928194046, -0.013246705755591393, -0.1200728490948677, -0.046609070152044296, 0.05038714036345482, 0.12761999666690826, 0.05169108510017395, -0.03306601941585541, -1.531399363167927e-32, -0.06956273317337036, 0.09222457557916641, -0.09570694714784622, -0.09215781837701797, -0.06723121553659439, -0.08053324371576309, -0.03836848959326744, 0.08749822527170181, 0.08491000533103943, 0.07587166875600815, 0.08173177391290665, 0.07714662700891495, -0.0072897495701909065, 0.053590383380651474, 0.006059568841010332, -0.03985514119267464, -0.1109909638762474, -0.09619004279375076, -0.05303680896759033, 0.09365805238485336, 0.011207659728825092, 0.0558633878827095, -0.08982431888580322, 0.38274070620536804, 0.129996657371521, -0.05534553527832031, 0.014556553214788437, 0.2545521855354309, 0.14889992773532867, -0.19320470094680786, -0.15173864364624023, -0.09409700334072113, -0.13356353342533112, -0.03190998733043671, 0.029639123007655144, -0.0602252297103405, 0.10673616826534271, -0.06816045194864273, 0.0029803484212607145, -0.02863437682390213, 0.1702338010072708, -0.14586181938648224, -0.013324577361345291, 0.09666742384433746, 0.124024398624897, 0.07953860610723495, -0.002950349124148488, 0.08471165597438812, 0.08544785529375076, -0.03147256001830101, -0.05559749901294708, 0.009797229431569576, 0.030435772612690926, 0.2763855457305908, -0.07266787439584732, 0.1154501810669899, -0.0460372269153595, 0.010373415425419807, -0.13680991530418396, -0.10548202693462372, 0.034137751907110214, 0.14218176901340485, -0.2342645227909088, -0.0688755139708519, -0.018761638551950455, -0.03478412702679634, 0.12803024053573608, -0.1009363904595375, 0.057260796427726746, -0.0161497350782156, -0.08029577881097794, -0.04270908609032631, -0.1494881510734558, -0.29740703105926514, -0.004224247764796019, 0.03435726836323738, 0.011752515099942684, 0.08681090921163559, -0.08905317634344101, 0.12994034588336945, 0.09038589149713516, -0.023604216054081917, -0.022662827745079994, -0.051104310899972916, -0.062044963240623474, 0.10698793083429337, 0.13721485435962677, -0.1400419920682907, -0.14626695215702057, 0.02619628608226776, -0.23482273519039154, -0.08512374758720398, -0.2599444091320038, 0.04851722717285156, -0.11983427405357361, -1.0033416231181036e-07, 0.1432850956916809, -0.040835440158843994, 0.03322886303067207, -0.003485986730083823, 0.1285872906446457, -0.11785204708576202, -0.11851118505001068, 0.0272959116846323, 0.07138580083847046, 0.19955267012119293, 0.15938526391983032, 0.10249229520559311, -0.028933387249708176, -0.1876693069934845, -0.017566699534654617, -0.050159960985183716, -0.18663936853408813, 0.16894327104091644, 0.10845693200826645, -0.1521286815404892, 0.10677599906921387, 0.11020796746015549, 0.20380756258964539, 0.006136339157819748, -0.013474982231855392, 0.13949930667877197, -0.09423761814832687, -0.08165104687213898, 0.08138985186815262, -0.0022915033623576164, 0.025042278692126274, 0.00946086272597313, 0.10862996429204941, -0.08796036243438721, -0.006740441080182791, 0.005663602147251368, 0.10865335166454315, 0.004371824208647013, 0.11062440276145935, -0.046291425824165344, 0.04434293508529663, -0.05970495194196701, 0.0005795987672172487, 0.04419073462486267, -0.09297635406255722, -0.059010010212659836, -0.0835733562707901, -0.024437667801976204, 0.17688564956188202, -0.24660152196884155, 0.010062610730528831, -0.12518595159053802, 0.12362231314182281, 0.043965138494968414, -0.08353514224290848, 0.09157489985227585, -0.15010294318199158, -0.07514020055532455, -0.22968189418315887, 0.21352018415927887, 0.17667004466056824, -0.3160732388496399, 0.04535707086324692, 0.16400021314620972], "changes": {"1wk": -8.69565668088043, "1mo": -28.260868015947356}}, {"text": "Cyclacel Pharmaceuticals, Inc. (CYCC) Reports Q3 Loss Zacks Equity Research Wed, Nov 13, 2024, 2:00 AM 3 min read In This Article: CYCC +4.50% Cyclacel Pharmaceuticals, Inc. (CYCC) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.54. This compares to loss of $7.35 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 66.67%. A quarter ago, it was expected that this company would post a loss of $0.83 per share when it actually produced a loss of $0.72, delivering a surprise of 13.25%. Over the last four quarters, the company has surpassed consensus EPS estimates four times. Cyclacel Pharmaceuticals , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $0.01 million for the quarter ended September 2024, in line with the Zacks Consensus Estimate. This compares to year-ago revenues of $0.02 million. The company has not been able to beat consensus revenue estimates over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Cyclacel Pharmaceuticals shares have lost about 83.2% since the beginning of the year versus the S&P 500's gain of 25.8%. What's Next for Cyclacel Pharmaceuticals? While Cyclacel Pharmaceuticals has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Cyclacel Pharmaceuticals: mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is -$0.40 on $0.01 million in revenues for the coming quarter and -$2.29 on $0.05 million in revenues for the current fiscal year. Story Continues Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Biomedical and Genetics is currently in the top 29% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. One other stock from the broader Zacks Medical sector, TriSalus Life Sciences, Inc. (TLSI), is yet to report results for the quarter ended September 2024. The results are expected to be released on November 14. This company is expected to post quarterly loss of $0.37 per share in its upcoming report, which represents a year-over-year change of -184.6%. The consensus EPS estimate for the quarter has been revised 4.1% higher over the last 30 days to the current level. TriSalus Life Sciences, Inc.'s revenues are expected to be $7.6 million, up 46.4% from the year-ago quarter. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Cyclacel Pharmaceuticals, Inc. (CYCC) : Free Stock Analysis Report TriSalus Life Sciences, Inc. (TLSI) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CYCC", "date": "2024-11-13T02:00:14", "sentiment": {"score": -0.609066516160965, "confidence": 0.6865711212158203, "probabilities": {"positive": 0.07750460505485535, "negative": 0.6865711212158203, "neutral": 0.23592425882816315}}, "embedding": [-0.1274847388267517, 0.01843940280377865, 0.03866166993975639, 0.06342635303735733, -0.051384590566158295, -0.01339787244796753, -0.0774860680103302, 0.17692357301712036, 0.263959139585495, 0.05142958462238312, -0.09947925806045532, 0.07962121814489365, 0.1236071065068245, 0.025607533752918243, -0.16983775794506073, -0.029569175094366074, 0.050353825092315674, 0.07232972979545593, -0.12716266512870789, 0.06079181283712387, -0.0749162957072258, -0.010316991247236729, 0.15696533024311066, 0.1178046464920044, 0.07628185302019119, 0.11473089456558228, -0.14609235525131226, 0.08414947986602783, -0.19440558552742004, -0.03325340524315834, -0.017087921500205994, 0.15758401155471802, 0.14728879928588867, -0.12015561014413834, 0.015480023808777332, -0.03196330741047859, -0.09795216470956802, 0.12912432849407196, 0.15392839908599854, -0.05047617107629776, -0.07533199340105057, 0.04878793656826019, -0.15969207882881165, 0.005332916975021362, -0.017292872071266174, -0.16507254540920258, -0.02505313605070114, -0.025802969932556152, 0.04435599967837334, 0.041943833231925964, -0.15837723016738892, -0.0757351964712143, 0.05163748934864998, 0.05551043152809143, -0.14529231190681458, 0.08781640976667404, -0.20923694968223572, -0.05915157124400139, 0.07485562562942505, 0.043997056782245636, 0.04866306856274605, 0.04755132645368576, 0.004174067173153162, 0.09727652370929718, 0.07234171032905579, 0.02969067543745041, 0.033515699207782745, 0.035079214721918106, -0.10365630686283112, 0.05899469181895256, 0.04822332412004471, -0.06286291778087616, -0.03346503525972366, 0.0247492678463459, -0.11064453423023224, 0.05233009532094002, 0.14708098769187927, 0.07623429596424103, 0.028428049758076668, -0.1086578518152237, 0.1276077777147293, -0.06680826097726822, -0.09215547144412994, -0.04866785556077957, 0.019817670807242393, -0.006683063693344593, 0.20774157345294952, 0.1099541038274765, 0.04291858524084091, 0.03381289169192314, 0.02055617794394493, 0.04009102284908295, -0.043995775282382965, -0.09666457772254944, 0.07388454675674438, 0.017227161675691605, -0.05271381884813309, -0.0578613355755806, 0.04681628942489624, 0.05932163447141647, 0.20125330984592438, 0.10234697163105011, -0.1041792780160904, -0.20885764062404633, -0.015596850775182247, -0.12453953176736832, 0.09926433861255646, -0.0221960861235857, 0.03111538477241993, 0.06714218854904175, -0.10658138990402222, 0.0506213903427124, -0.17900028824806213, -0.09352922439575195, -0.06285113841295242, 0.1122346818447113, 0.05267053842544556, 0.10318708419799805, 0.0912494957447052, 0.07258839905261993, 0.014604096300899982, -0.020881909877061844, -0.01668601483106613, -0.01458432525396347, 0.045303549617528915, 0.07486426830291748, -0.16905418038368225, 7.687596403159477e-33, 0.032024018466472626, 0.08014827221632004, 0.05188343673944473, 0.003254408948123455, -0.02168082818388939, 0.05823928117752075, 0.11758003383874893, -0.0513727031648159, -0.028381261974573135, -0.14689257740974426, -0.1955176591873169, 0.04643974080681801, -0.02773982658982277, -0.09590400755405426, -0.0032633785158395767, -0.05379023030400276, -0.08476393669843674, 0.05080583691596985, 0.015433966182172298, -0.08090676367282867, -0.06816454231739044, -0.0386868417263031, -0.030608931556344032, 0.052369408309459686, 0.03998506814241409, 0.07062382996082306, -0.08543673157691956, 0.018249845132231712, -0.12175609171390533, 0.0036710170097649097, -0.029501188546419144, 0.03389333561062813, 0.04057092219591141, -0.11232281476259232, -0.03256469964981079, -0.06337302923202515, -0.04375326633453369, -0.028432035818696022, 0.1867801547050476, 0.061152148991823196, -0.1739601194858551, 0.007814590819180012, -0.1334763616323471, -0.17267385125160217, -0.02845475822687149, 0.030844757333397865, -0.12209562957286835, 0.08617529273033142, -0.1292078197002411, -0.07530202716588974, 0.07266122847795486, 0.018723610788583755, -0.07826566696166992, 0.030437692999839783, -0.08320891857147217, 0.08841481804847717, -0.10244005918502808, -0.18243637681007385, 0.03727924823760986, 0.18080073595046997, 0.09625620394945145, 0.324212908744812, -0.004543589428067207, -0.04426339268684387, -0.18728309869766235, 0.18926703929901123, -0.07066840678453445, 0.05670680105686188, -0.1924281120300293, 0.2735145688056946, 0.019009772688150406, -0.08587484061717987, 0.1074063777923584, 0.03591352701187134, 0.25008130073547363, -0.0016152672469615936, -0.09302183985710144, -0.06805716454982758, 0.1814746856689453, 0.09956321120262146, 0.06586891412734985, -0.08550243824720383, 0.016667213290929794, 0.0090310238301754, 0.029064737260341644, -0.07384051382541656, 0.07149524986743927, -0.027924396097660065, 0.0011923890560865402, 0.018496647477149963, 0.06776975095272064, -0.2433287501335144, -0.03787316009402275, 0.14163054525852203, 0.004827793687582016, -9.023464182948419e-33, -0.018758483231067657, 0.08689205348491669, 0.03556910902261734, -0.04798782244324684, -0.06107049807906151, -0.058070532977581024, 0.002677648328244686, -0.023902829736471176, 0.08649211376905441, -0.06235601007938385, 0.03721658140420914, 0.04575979337096214, -0.11311091482639313, 0.17163705825805664, -0.12309755384922028, 0.009571024216711521, 0.11570219695568085, -0.1480082869529724, -0.007155999541282654, -0.028349677100777626, 0.008354254066944122, 0.10029934346675873, -0.05139048397541046, 0.14730118215084076, 0.01894773729145527, 0.06631093472242355, 0.08695398271083832, 0.2034396529197693, 0.09406402707099915, -0.05903876572847366, -0.04745347425341606, 0.02247428335249424, -0.1534838080406189, 0.016459370031952858, 0.05598728358745575, 0.060818012803792953, -0.11239573359489441, -0.24310818314552307, -0.004768800921738148, -0.06080057471990585, 0.0809224396944046, -0.02340453490614891, -0.010324008762836456, 0.036800891160964966, 0.1140684187412262, -0.016856035217642784, 0.04100925475358963, -0.019352875649929047, 0.25682511925697327, 0.07026524841785431, 0.03693742677569389, 0.07203167676925659, -0.0684550553560257, 0.19557714462280273, -0.10338236391544342, 0.0954311341047287, -0.0951952263712883, 0.021696094423532486, -0.07865041494369507, 0.0007547717541456223, -0.0232249703258276, 0.15173470973968506, -0.0156952403485775, 0.06068318337202072, 0.027631307020783424, 0.053908031433820724, 0.021870248019695282, 0.013463523238897324, 0.0222187340259552, -0.14244858920574188, 0.0749986320734024, -0.12159270793199539, 0.05178075656294823, -0.18556684255599976, 0.004270115867257118, 0.25765129923820496, -0.07640824466943741, -0.14519721269607544, -0.10170374810695648, 0.02714042365550995, 0.11461928486824036, 0.035124897956848145, 0.028751477599143982, -0.002869792515411973, -0.20480722188949585, 0.12094059586524963, 0.012049463577568531, -0.01506085880100727, -0.08995327353477478, -0.07589294016361237, -0.0382225327193737, -0.14507673680782318, -0.0880863219499588, 0.1083567887544632, 0.09990804642438889, -9.992663763114251e-08, 0.05292791500687599, -0.07451087236404419, 0.06473236531019211, -0.07396161556243896, 0.128301739692688, -0.03132394701242447, 0.054340213537216187, -0.045369282364845276, 0.09406547248363495, 0.11647392064332962, 0.08753247559070587, 0.05552425980567932, -0.20152270793914795, 0.05991356819868088, -0.1794709712266922, 0.08979339897632599, -0.169866144657135, 0.0029882285743951797, 0.05159403756260872, -0.16230617463588715, -0.10255813598632812, 0.05153517425060272, -0.0056228782050311565, -0.11774259060621262, 0.06450024247169495, -0.1809711456298828, -0.0365665927529335, -0.022553473711013794, -0.030815480276942253, -0.018026575446128845, 0.11816064268350601, -0.07296831160783768, 0.08982914686203003, 0.09968657791614532, 0.014358443208038807, -0.08590073138475418, 0.01638875901699066, 0.03005646914243698, 0.03724246099591255, 0.032071858644485474, -0.10604541003704071, 0.024452276527881622, -0.03751103952527046, 0.01924007013440132, -0.07095280289649963, -0.14094410836696625, -0.09810236096382141, 0.004665648564696312, 0.018928276374936104, -0.27362197637557983, 0.11705902218818665, -0.03117828257381916, 0.012600173242390156, -0.0020667389035224915, 0.14484582841396332, 0.05913902074098587, -0.19953656196594238, -0.03530748561024666, -0.19416600465774536, -0.07367387413978577, -0.08936680108308792, -0.2660229206085205, 0.10151973366737366, 0.1300588697195053], "changes": {"1wk": -9.756095610793878, "1mo": -9.756095610793878}}, {"text": "Cyclacel Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update Cyclacel Wed, Nov 13, 2024, 12:45 AM 7 \u5206\u9418\u95b1\u8b80\u6642\u9593 \u5728\u9019\u7bc7\u6587\u7ae0\u4e2d: CYCC +4.50% CYCCP -8.24% Cyclacel BERKELEY HEIGHTS, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; \"Cyclacel\" or the \"Company\"), a biopharmaceutical company developing innovative medicines, today announced third quarter financial results and provided a business update. \u201cWe were pleased to report initial safety and efficacy data from twelve patients with advanced solid tumors enrolled in the Phase 2 part of the 065-101, proof of concept, clinical study of fadraciclib as a single agent as a poster presentation at the 2024\u00a0EORTC-NCI-AACR 36 th Symposium on Molecular Targets and Cancer Therapeutics (\u201cTriple Meeting\u201d), in Barcelona, Spain. The patients were enrolled in the biomarker-enriched, Cohort 8 of the study and were preselected for CDKN2A and/or CDKN2B abnormalities,\u201d said Spiro Rombotis, President and Chief Executive Officer. \u201cNasdaq has granted the Company an extension until December 24, 2024, to regain compliance with Nasdaq\u2019s minimum stockholders\u2019 equity requirement and we continue to pursue opportunities to obtain additional funding for our programs. If we do not secure such additional funding in an amount that allows us to meet or exceed Nasdaq\u2019s minimum stockholders\u2019 equity requirement, our securities will be delisted from Nasdaq.\u201d Financial Highlights As of September 30, 2024, cash equivalents totaled $3.0 million, compared to $3.4 million as of December 31, 2023. Net cash used in operating activities was $6.6 million for the nine months ended September 30, 2024 compared to $12.2 million for the same period of 2023. The Company estimates that its available cash will fund currently planned programs into the fourth quarter of 2024. Although the Company has made substantial reductions in its expenses, there remains substantial doubt about our ability to continue as a going concern. We are currently investigating ways to raise additional capital through private equity financing or by entering into a strategic transaction. In the event that we are not able to secure such additional funding, we may be forced to curtail operations, delay or stop ongoing development activities, cease operations altogether, and/or file for bankruptcy. In such events, our stockholders may lose their entire investment in the Company. Research and development (R&D) expenses were $1.0 million for the three months ended September 30, 2024, as compared to $5.2 million for the same period in 2023. R&D expenses relating to fadraciclib were $0.9 million for the three months ended September 30, 2024, as compared to $3.6 million for the same period in 2023 due to manufacturing costs not recurring in 2024. R&D expenses related to plogosertib were $0.1 million for the three months ended September 30, 2024, as compared to $1.5 million for the same period in 2023 also due to manufacturing costs not recurring in 2024. \u7e7c\u7e8c\u95b1\u8b80 General and administrative expenses for the three months ended September 30, 2024 were $1.2 million, as compared to $1.6 million for the same period in 2023 due largely to reduction in stock compensation costs. Total other income, net, for the three months ended September 30, 2024 was $10,000 compared to an income of $145,000 for the same period of the previous year. United Kingdom research & development tax credits for the three months ended September 30, 2024 were $0.2 million compared to $0.7 million for the same period of the previous year. Research & development tax credits are directly correlated to qualifying research and development expenditure. Net loss for the three months ended September 30, 2024 was $2.0 million, compared to $6.0 million for the same period in 2023. About Cyclacel Pharmaceuticals, Inc. Cyclacel\u00a0is a clinical-stage, biopharmaceutical company developing innovative cancer medicines based on cell cycle, transcriptional regulation and mitosis biology. The transcriptional regulation program is evaluating fadraciclib, a CDK2/9 inhibitor, and the anti-mitotic program plogosertib, a PLK1 inhibitor, in patients with both solid tumors and hematological malignancies. Cyclacel's\u00a0strategy is to build a diversified biopharmaceutical business based on a pipeline of novel drug candidates addressing oncology and hematology indications. For additional information, please visit www.cyclacel.com . Forward-looking Statements This news release contains certain forward-looking statements that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. Such forward-looking statements include, among other things, statements related to the efficacy and safety profile of fadraciclib in an incomplete clinical trial, Cyclacel\u2019s future plans and prospects, Cyclacel\u2019s anticipated cash runway and its ability to secure additional funding and the planned timing of data results and continued development of fadraciclib. Factors that may cause actual results to differ materially include market and other conditions, the risk that product candidates that appeared promising in early research and clinical trials do not demonstrate safety and/or efficacy in larger-scale or later clinical trials, trials may have difficulty enrolling,\u00a0Cyclacel\u00a0may not obtain approval to market its product candidates, the risks associated with reliance on outside financing to meet capital requirements, the risks associated with reliance on collaborative partners for further clinical trials, development and commercialization of product candidates and Cyclacel\u2019s ability to regain and maintain compliance with Nasdaq\u2019s continued listing requirements, although no assurance to that effect can be given. You are urged to consider statements that include the words \"may,\" \"will,\" \"would,\" \"could,\" \"should,\" \"believes,\" \"estimates,\" \"projects,\" \"potential,\" \"expects,\" \"plans,\" \"anticipates,\" \"intends,\" \"continues,\" \"forecast,\" \"designed,\" \"goal,\" or the negative of those words or other comparable words to be uncertain and forward-looking. For a further list and description of the risks and uncertainties the Company faces, please refer to our most recent Annual Report on Form 10-K and other periodic and other filings we file with the\u00a0Securities and Exchange Commission\u00a0and are available at www.sec.gov . Such forward-looking statements are current only as of the date they are made, and we assume no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. Contacts Company: Paul McBarron, (908) 517-7330, pmcbarron@cyclacel.com \u00a9 Copyright 2024 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. The Cyclacel logo and Cyclacel\u00ae are trademarks of Cyclacel Pharmaceuticals, Inc. SOURCE: Cyclacel Pharmaceuticals, Inc. CYCLACEL PHARMACEUTICALS, INC. CONSOLIDATED STATEMENTS OF OPERATIONS (LOSS) (In $000s, except share and per share amounts) Three Months Ended September 30, 2024 2023 Revenues: Collaboration and research and development revenue 10 16 Revenues $ 10 $ 16 Operating expenses: Research and development 950 5,236 General and administrative 1,237 1,625 Total operating expenses 2,187 6,861 Operating loss (2,177 ) (6,845 ) Other income (expense): Foreign exchange gains (losses) 2 104 Interest income 8 50 Other income, net - (9 ) Total other income (expense), net 10 145 Loss before taxes (2,167 ) (6,700 ) Income tax benefit 210 668 Net loss (1,957 ) (6,032 ) Dividend on convertible exchangeable preferred shares - (50 ) Net loss applicable to common shareholders $ (1,957 ) $ (6,082 ) Basic and diluted earnings per common share: Net loss per share \u2013 basic and diluted (common shareholders) $ (0.18 ) $ (0.48 ) Net loss per share \u2013 basic and diluted (redeemable common shareholders) $ - $ (0.48 ) CYCLACEL PHARMACEUTICALS, INC. CONSOLIDATED BALANCE SHEET (In $000s, except share, per share, and liquidation preference amounts) September 30, December 31, 2024 2023 ASSETS Current assets: Cash and cash equivalents $ 2,982 $ 3,378 Prepaid expenses and other current assets 1,931 4,066 Total current assets 4,913 7,444 Property and equipment, net 4 9 Right-of-use lease asset 51 93 Non-current deposits 413 1,259 Total assets $ 5,381 $ 8,805 LIABILITIES AND STOCKHOLDERS\u2019 EQUITY Current liabilities: Accounts payable $ 4,126 $ 3,543 Accrued and other current liabilities 2,225 4,618 Total current liabilities 6,351 8,161 Lease liability - 37 Total liabilities 6,351 8,198 Stockholders\u2019 equity (970 ) 607 Total liabilities and stockholders\u2019 equity $ 5,381 $ 8,805 \u67e5\u770b\u7559\u8a00 \u689d\u6b3e \u53ca \u79c1\u96b1\u653f\u7b56 Privacy Dashboard \u63a8\u85a6\u65b0\u805e", "symbol": "CYCC", "date": "2024-11-13T00:45:00", "sentiment": {"score": 0.8743047304451466, "confidence": 0.8944680094718933, "probabilities": {"positive": 0.8944680094718933, "negative": 0.02016327902674675, "neutral": 0.08536866307258606}}, "embedding": [-0.09031189978122711, -0.09690378606319427, -0.0352424792945385, -0.09525094926357269, -0.07036294788122177, -0.06888359785079956, -0.06270775198936462, 0.17626261711120605, 0.14689625799655914, 0.03715730458498001, -0.08515024185180664, 0.0215859804302454, 0.0910373255610466, -0.01086866669356823, -0.047230470925569534, 0.030525142326951027, -0.03291699290275574, 0.029437407851219177, -0.11678856611251831, 0.12789803743362427, -0.06324435770511627, -0.006790356710553169, 0.12725494801998138, 0.12299809604883194, 0.021512417122721672, -0.04613029956817627, -0.07216597348451614, 0.01772705838084221, -0.1567300260066986, -0.023452267050743103, 0.14898546040058136, 0.13799899816513062, 0.013880743645131588, -0.07925298810005188, 0.12095743417739868, 0.013744090683758259, -0.12046678364276886, 0.1144208088517189, -0.05186391994357109, -0.0613039955496788, -0.027641888707876205, -0.04995086044073105, -0.0827903151512146, 0.14589360356330872, -0.031929582357406616, -0.1152331680059433, -0.06632666289806366, -0.02105390653014183, 0.04702136665582657, 0.10524732619524002, -0.09769853204488754, -0.1077786535024643, -0.026711957529187202, 0.10419947654008865, 0.0018568127416074276, 0.07957105338573456, -0.1974368393421173, -0.009123106487095356, -0.0032048169523477554, 0.03578479215502739, -0.00958818756043911, 0.01914273574948311, -0.0032887328416109085, 0.06338059157133102, 0.10900428146123886, 0.12171251326799393, -0.0055499086156487465, -0.05572762340307236, -0.0155978724360466, 0.01822868548333645, 0.0794469565153122, -0.09183141589164734, 0.0022388724610209465, 0.05138767883181572, -0.09205131232738495, 0.09227769821882248, 0.10322538018226624, 0.16377562284469604, 0.10675492882728577, -0.12428274750709534, 0.04434940218925476, -0.023096170276403427, 0.08653655648231506, -0.021763266995549202, -0.009757915511727333, -0.00895096454769373, 0.04305370897054672, 0.12967844307422638, -0.019870596006512642, 0.02774517424404621, 0.2202245146036148, 0.0727170780301094, 0.005343161523342133, -0.020636217668652534, -0.028820201754570007, -0.05424007773399353, -0.005519400350749493, 0.008553664200007915, 0.0719740092754364, 0.03136193007230759, 0.11409067362546921, 0.022475367411971092, -0.08269724249839783, -0.15480123460292816, -0.03984454274177551, -0.09366374462842941, 0.014953544363379478, -0.07797949016094208, -0.05909413844347, -0.03558029234409332, -0.08009092509746552, 0.03134143352508545, -0.06743229925632477, -0.06897346675395966, -0.024483419954776764, 0.1949205994606018, -0.013890977948904037, -0.003295823000371456, 0.1836014986038208, -0.11927853524684906, -0.004464958794414997, 0.03103308007121086, 0.006459950003772974, -0.09753483533859253, 0.029125094413757324, 0.021334249526262283, -0.15204963088035583, 1.0865416076228941e-32, -0.04241456091403961, 0.0014896262437105179, 0.10428750514984131, 0.030381102114915848, -0.006333786062896252, 0.004562617279589176, 0.0949808806180954, -0.0425724983215332, -0.11613684892654419, -0.06488555669784546, -0.09926165640354156, 0.039582762867212296, 0.014353652484714985, -0.049422528594732285, -0.0526113286614418, -0.08449403941631317, -0.10000090301036835, 0.006188129540532827, -0.025101538747549057, -0.04097520932555199, 0.01664603501558304, 0.053310662508010864, -0.04507339373230934, 0.1015382707118988, 0.003647984005510807, 0.07031644135713577, -0.11289012432098389, 0.067875437438488, 0.06854183226823807, 0.05459963157773018, -0.153880313038826, 0.010401858948171139, 0.0007414171705022454, -0.024167107418179512, -0.0870136022567749, -0.03678816184401512, -0.11867310106754303, -0.12818554043769836, 0.04444284737110138, 0.08586662262678146, 0.021494019776582718, 0.006158017553389072, -0.006246520206332207, -0.10155937075614929, 0.02362372912466526, -0.015992790460586548, -0.09879143536090851, 0.11032575368881226, -0.10598865896463394, -0.05515224114060402, 0.046391479671001434, 0.031797874718904495, -0.08284187316894531, 0.0013580583035945892, -0.10766439139842987, -0.00851263478398323, -0.1354036182165146, -0.12046599388122559, 0.009032242000102997, 0.1111706793308258, 0.06631283462047577, 0.09733925759792328, -0.017318647354841232, 0.010926824994385242, -0.14095649123191833, 0.1423048973083496, -0.0647847130894661, -0.06736142933368683, -0.08437060564756393, 0.17241701483726501, -0.01551186852157116, -0.036152929067611694, 0.1705765575170517, 0.10204767435789108, 0.11967679113149643, -0.056751690804958344, 0.048200029879808426, 0.02099713310599327, 0.00955866277217865, 0.15636038780212402, -0.0069261593744158745, -0.0851496085524559, -0.013594551011919975, 0.13931557536125183, -0.0005840267986059189, -0.101127490401268, 0.05095250532031059, -0.05186058208346367, -0.06847228109836578, 0.030088789761066437, 0.0326693058013916, -0.15870848298072815, -0.049861058592796326, 0.14300014078617096, -0.026201535016298294, -1.2211094091059464e-32, 0.03778200224041939, 0.009704425930976868, 0.061888281255960464, -0.07295693457126617, -0.009699251502752304, 0.03689116984605789, 0.0536152683198452, -0.13094456493854523, 0.07090878486633301, -0.14567351341247559, 0.03528100997209549, 0.0667090192437172, 0.016451412811875343, -0.020369626581668854, -0.09542475640773773, 0.028028037399053574, -0.020263956859707832, -0.03125631436705589, -0.049397148191928864, 0.04580412060022354, 0.0030080024152994156, 0.1419067531824112, -0.0574970580637455, 0.12990304827690125, 0.06257724016904831, 0.038972605019807816, 0.0855739414691925, 0.0958680585026741, 0.07550206780433655, -0.00842133816331625, -0.07538983225822449, 0.03993133455514908, -0.24116912484169006, -0.0013137641362845898, -0.03469917178153992, -0.037933871150016785, 0.06927092373371124, -0.24843454360961914, -0.04829415678977966, -0.08477822691202164, 0.03314788639545441, -0.0016599306836724281, -0.07679564505815506, 0.10992182791233063, 0.09011750668287277, 0.014839696697890759, 0.06487353146076202, -0.033183515071868896, 0.13633039593696594, -0.02753431349992752, 0.009195862337946892, 0.030995789915323257, 0.06415597349405289, 0.12035413086414337, -0.0073522236198186874, 0.11990293860435486, 0.06576275080442429, -0.05242278054356575, 0.07470285892486572, -0.045119136571884155, 0.0045504337176680565, 0.06792554259300232, -0.05630902945995331, -0.008868022821843624, 0.07960161566734314, 0.06617072224617004, 0.03698776662349701, 0.03544658049941063, -0.08551900088787079, -0.09448076784610748, -0.015561777167022228, -0.08581393957138062, 0.005059659481048584, -0.05716060847043991, -0.02324432134628296, 0.1928558498620987, 0.0048763081431388855, -0.10418820381164551, -0.09580136090517044, 0.021059665828943253, 0.020823607221245766, -0.048392437398433685, 0.028161287307739258, 0.006140940822660923, -0.0039984239265322685, 0.08783765137195587, 0.044861484318971634, -0.03496305271983147, -0.1010439395904541, -0.07342486083507538, -0.08649793267250061, -0.08095979690551758, -0.0869300365447998, 0.15073232352733612, 0.06566759198904037, -1.0035100928007523e-07, 0.10336166620254517, -0.06206780672073364, -0.06317362189292908, -0.16966450214385986, 0.1301705539226532, -0.03492587059736252, -0.08394689112901688, 0.06948523223400116, 0.002091681584715843, 0.12408246845006943, 0.0417361855506897, 0.17714032530784607, -0.11130835115909576, -0.0021409057080745697, -0.17510467767715454, 0.1518576741218567, -0.11531738936901093, -0.05649706721305847, -0.04118283838033676, -0.030238863080739975, -0.12230796366930008, 0.0772281289100647, -0.037428490817546844, -0.06036349758505821, 0.0345425009727478, -0.08200579881668091, 0.01068736333400011, 0.1670931577682495, -0.01166321150958538, -0.020548293367028236, 0.0074836015701293945, -0.09085564315319061, 0.05585378408432007, 0.0037709102034568787, -0.016704542562365532, -0.03985383361577988, 0.06837788224220276, 0.01805848628282547, 0.042823098599910736, 0.14003613591194153, -0.01682109199464321, -0.014729245565831661, -0.026633108034729958, 0.03840862959623337, -0.010647822171449661, -0.12685154378414154, -0.19706138968467712, 0.028474504128098488, 0.07074259966611862, -0.15122109651565552, 0.028723981231451035, 0.012675833888351917, -0.03755224496126175, -0.03662481531500816, 0.06326300650835037, 0.09639482945203781, -0.14464685320854187, 0.021706851199269295, -0.022431930527091026, -0.03289861977100372, -0.024774104356765747, -0.18975311517715454, 0.0958956703543663, 0.016831472516059875], "changes": {"1wk": -9.756095610793878, "1mo": -9.756095610793878}}, {"text": "Cyclacel Pharmaceuticals Announces Its Exploration of Potential Strategic Alternatives and Reduction of Operating Costs Cyclacel Fri, Dec 6, 2024, 12:05 AM 4 min read In This Article: CYCC +4.50% CYCCP -8.24% Cyclacel BERKELEY HEIGHTS, N.J., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; \"Cyclacel\" or the \"Company\"), a biopharmaceutical company developing innovative cancer medicines, today announced that it is in the process of exploring and reviewing strategic alternatives on an expedited basis in order to preserve the Company\u2019s cash, including a potential transaction with investor David Lazar of Activist Investing, LLC, which transaction would be subject to the consent of an existing securityholder. The Company\u2019s Board of Directors is reviewing a range of appropriate strategies to realize value from its assets. The Board has directed management to reduce operating costs while such alternatives are being explored. There can be no assurance that the exploration of strategic alternatives will result in any agreement or transaction, or as to the timing of any such agreement or transaction. Further, there can be no assurance that the Company will be able to reach an agreement, or consummate a transaction, with Mr. Lazar or receive the required consent of an existing securityholder to any such transaction. As previously disclosed, the Company does not presently meet the continued listing requirements of the Nasdaq Stock Market and its securities would be subject to delisting if the Company fails to regain compliance during the required compliance period. In the event that the Company is not able to enter into a strategic transaction and/or secure additional funding, it may be forced to cease all business operations. In such event, the Company\u2019s stockholders may lose a part or all of their investment in the Company. About Cyclacel Pharmaceuticals, Inc. Cyclacel is a clinical-stage, biopharmaceutical company developing innovative cancer medicines based on cell cycle, transcriptional regulation and mitosis biology. The transcriptional regulation program is evaluating fadraciclib, a CDK2/9 inhibitor, and the anti-mitotic program plogosertib, a PLK1 inhibitor, in patients with both solid tumors and hematological malignancies. Cyclacel's strategy is to build a diversified biopharmaceutical business based on a pipeline of novel drug candidates addressing oncology and hematology indications. For additional information, please visit www.cyclacel.com. Forward-looking Statements This news release contains certain forward-looking statements that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. Such forward-looking statements include, among other things, statements related to the Company\u2019s exploration and review of strategic alternatives, its ability to identify and complete a transaction as a result of the strategic review process, including a potential transaction with David Lazar, its plans to reduce costs and conserve cash and Cyclacel\u2019s ability to regain and maintain compliance with Nasdaq\u2019s continued listing requirements. You are urged to consider statements that include the words \"may,\" \"will,\" \"would,\" \"could,\" \"should,\" \"believes,\" \"estimates,\" \"projects,\" \"potential,\" \"expects,\" \"plans,\" \"anticipates,\" \"intends,\" \"continues,\" \"forecast,\" \"designed,\" \"goal,\" or the negative of those words or other comparable words to be uncertain and forward-looking. These risks and uncertainties include the risk that the Company may not be successful in exploring strategic alternatives and consummating one or more strategic transactions on attractive terms, if at all; the Company\u2019s actual reductions in spending as compared to anticipated cost reductions; the Company\u2019s costs of continuing to operate as a public company; and the other risks described more fully in Cyclacel Pharmaceuticals\u2019 filings with the Securities and Exchange Commission, including the \u201cRisk Factors\u201d section of the Company\u2019s Annual Report on Form 10-K for the year ending December 31, 2023 and its other documents subsequently filed with or furnished to the Securities and Exchange Commission, including its Form 10-Q for the quarter ended September 30, 2024. For a further list and description of the risks and uncertainties the Company faces, please refer to our most recent Annual Report on Form 10-K and other periodic and other filings we file with the\u00a0Securities and Exchange Commission\u00a0and are available at www.sec.gov . Such forward-looking statements are current only as of the date they are made, and we assume no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. Story Continues Contacts Company: Paul McBarron, (908) 517-7330, IR@cyclacel.com \u00a9 Copyright 2024 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. The Cyclacel logo and Cyclacel\u00ae are trademarks of Cyclacel Pharmaceuticals, Inc. View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CYCC", "date": "2024-12-06T00:05:00", "sentiment": {"score": -0.0988969411700964, "confidence": 0.12875443696975708, "probabilities": {"positive": 0.029857495799660683, "negative": 0.12875443696975708, "neutral": 0.8413881063461304}}, "embedding": [-0.06454692780971527, 0.0010954015888273716, -0.12196983397006989, -0.19354945421218872, -0.10998080670833588, 0.012620671652257442, 0.022055529057979584, 0.13785013556480408, 0.2055104374885559, 0.002796289511024952, -0.03164961189031601, 0.02476518228650093, 0.10197073966264725, 0.004955516196787357, -0.07043714076280594, -0.03428182378411293, -0.02776096761226654, 0.10822484642267227, -0.17014434933662415, 0.12476254999637604, -0.012778539210557938, -0.05879862606525421, 0.06390591710805893, 0.11573410034179688, -0.08023687452077866, -0.07323101907968521, -0.040466129779815674, 0.07449018955230713, -0.14308291673660278, -0.06374245882034302, 0.14891807734966278, 0.19995486736297607, 0.07456119358539581, -0.11323283612728119, 0.13377566635608673, 0.07533647119998932, -0.18198102712631226, 0.053192224353551865, -0.028453223407268524, -0.07981327176094055, -0.048325683921575546, -0.017917834222316742, -0.14351528882980347, 0.09638740122318268, 0.017630765214562416, -0.12392071634531021, -0.10410039126873016, -0.039084214717149734, 0.01964358426630497, 0.040547989308834076, -0.11673104763031006, -0.08656463027000427, -0.06699825823307037, 0.07142019271850586, -0.08987744152545929, 0.08945931494235992, -0.17335304617881775, -0.028404349461197853, 0.06284081190824509, -0.04162440076470375, 0.11640813946723938, 0.010700850747525692, 0.009073344059288502, 0.07852497696876526, 0.05675230920314789, 0.11668436229228973, -0.019795823842287064, -0.022720694541931152, -0.07212059199810028, 0.034831494092941284, 0.05748307704925537, -0.1690041720867157, -0.11789627373218536, 0.0877520814538002, -0.11676124483346939, 0.08495143800973892, 0.10468514263629913, 0.13179419934749603, 0.0634583830833435, -0.1225382536649704, 0.0799928680062294, -0.0006644115783274174, 0.03570881858468056, -0.04751668497920036, -0.06477589905261993, -0.05056656897068024, 0.03637515380978584, 0.13359937071800232, 0.14272257685661316, 0.007451594807207584, 0.12277643382549286, 0.07461098581552505, 0.026450425386428833, -0.13088655471801758, 0.019535645842552185, -0.05187882483005524, 0.02046802267432213, -0.022109512239694595, 0.004539129324257374, -0.015668289735913277, 0.13543982803821564, -0.007830362766981125, -0.11142124980688095, -0.13457439839839935, -0.11447732895612717, -0.08482144773006439, 0.025255490094423294, -0.07114867866039276, -0.06448927521705627, 0.0013893209397792816, -0.1516401469707489, 0.01848517917096615, -0.04740064591169357, -0.10986602306365967, -0.06812033802270889, 0.20706400275230408, -0.06683284789323807, -0.009123518131673336, 0.16145771741867065, -0.16392791271209717, 0.031835902482271194, -0.004745423793792725, 0.01744530349969864, -0.08831290900707245, 0.015669213607907295, 0.015283895656466484, -0.17034700512886047, 6.426427615945446e-33, -0.11195454001426697, -0.027066601440310478, -5.9196725487709045e-05, -0.0077640339732170105, 0.02383851632475853, -0.01325313188135624, 0.16272026300430298, -0.047295942902565, -0.18009504675865173, -0.0433700829744339, -0.1182062178850174, 0.0603141188621521, -0.002766139805316925, -0.0848345011472702, -0.012262030504643917, -0.08712303638458252, -0.02310933731496334, 0.02572658658027649, 0.06539208441972733, -0.08085042238235474, 0.02685553766787052, -0.011849073693156242, -0.01144091784954071, 0.09466191381216049, 0.02404094859957695, -0.012780717574059963, -0.10080111026763916, -0.015159817412495613, 0.07605135440826416, 0.027221333235502243, -0.08397847414016724, 0.05623997002840042, -0.032960452139377594, 0.004333364777266979, 0.021880798041820526, -0.012176357209682465, -0.1991124153137207, -0.0690605565905571, 0.13746464252471924, 0.05532211810350418, -0.0479433611035347, -0.04968845844268799, -0.07584273815155029, 0.008316314779222012, 0.053395822644233704, 0.049404364079236984, -0.1029842346906662, 0.08309251070022583, -0.11661512404680252, 0.0016741454601287842, 0.030034232884645462, -0.01141466572880745, -0.07310175150632858, -0.017828091979026794, -0.10703453421592712, -0.03174123167991638, -0.17399534583091736, -0.05472492426633835, -0.05049780756235123, 0.1620616316795349, 0.03193829953670502, 0.11988142132759094, -0.06199497729539871, 0.06551698595285416, -0.07190200686454773, 0.11448594182729721, -0.12823785841464996, -0.08418387174606323, -0.1347464621067047, 0.09772518277168274, -0.03199043124914169, -0.06175357103347778, 0.2654728591442108, 0.10291820019483566, 0.13509467244148254, -0.05599752068519592, 0.003167318645864725, 0.10784809291362762, 0.03867729380726814, 0.12081027776002884, -0.04175490140914917, -0.038713861256837845, -0.01400761678814888, 0.1214427649974823, 0.00614682212471962, -0.14546748995780945, 0.05200576409697533, -0.018640492111444473, -0.06621038168668747, 0.09207174926996231, 0.01997937448322773, -0.15025900304317474, 0.002820947440341115, 0.27200376987457275, 0.12746992707252502, -8.737869748892482e-33, 0.07110580801963806, -0.09820593893527985, 0.09113419055938721, -0.08219597488641739, 0.017003433778882027, 0.027865488082170486, -0.015675393864512444, -0.20290833711624146, 0.0938986986875534, -0.14935611188411713, -0.06328455358743668, 0.06270907819271088, 0.045202143490314484, -0.016446765512228012, -0.1529601812362671, -0.03897130489349365, 0.03210160508751869, -0.036175377666950226, -0.10335084795951843, 0.09881377220153809, -0.031836483627557755, 0.11055546998977661, -0.058506764471530914, 0.14423003792762756, 0.04278528317809105, 0.08387898653745651, 0.08627762645483017, 0.08579336106777191, 0.0732988640666008, 0.013331381604075432, -0.07436326891183853, 0.045678652822971344, -0.20226657390594482, 0.030419811606407166, -0.011143265292048454, -0.045586664229631424, 0.054595947265625, -0.1787901669740677, 0.0543263703584671, 0.007264704443514347, 0.05105645954608917, -0.00044534914195537567, -0.02130255661904812, 0.04951436072587967, 0.09227053821086884, -0.03381442278623581, 0.07498340308666229, -0.10526503622531891, 0.17079031467437744, -0.00462694838643074, 0.07997322827577591, 0.08807551860809326, 0.11026231199502945, 0.062002032995224, -0.009533223696053028, 0.17662551999092102, 0.05200662463903427, -0.03987566754221916, 0.08857405185699463, -0.005590987857431173, 0.10536198318004608, 0.12234792113304138, 0.04670020565390587, 0.010521497577428818, 0.13162675499916077, 0.10804575681686401, 0.007849020883440971, 0.05434378236532211, 0.008881744928658009, -0.08743301033973694, 0.019094813615083694, -0.1317751407623291, 0.0006021596491336823, -0.10128483176231384, 0.09391400218009949, 0.08367174863815308, -0.044700805097818375, -0.2148762047290802, -0.10181352496147156, -0.023596271872520447, 0.04115748405456543, 0.001928053330630064, -0.017280511558055878, 0.0707053393125534, -0.04989182576537132, 0.017608774825930595, -0.008123739622533321, -0.020034536719322205, -0.03221813216805458, -0.10391700267791748, -0.024999694898724556, -0.07998395711183548, -0.014841918833553791, 0.20789319276809692, 0.032987695187330246, -1.003268152999226e-07, 0.07086776942014694, -0.13589493930339813, 0.006717796437442303, -0.16602884232997894, 0.16569587588310242, -0.04353168606758118, -0.015199944376945496, -0.06078372150659561, 0.043093327432870865, 0.12537583708763123, 0.03297162055969238, 0.15364962816238403, -0.1284872591495514, 0.056489940732717514, -0.17863954603672028, 0.07731325179338455, -0.10925029218196869, -0.042683687061071396, -0.028996631503105164, 0.0013056548777967691, -0.08608990907669067, 0.034310437738895416, -0.08646628260612488, -0.0289473719894886, 0.05404846742749214, -0.1437201201915741, 0.10004781186580658, 0.065899558365345, 0.060999467968940735, 0.02565724030137062, 0.05931570753455162, -0.0582164004445076, 0.13441413640975952, 0.09348385035991669, -0.036610834300518036, -0.06280019879341125, 0.09787609428167343, 0.04150817170739174, 0.03102111630141735, 0.07357857376337051, -0.0684976726770401, 0.08501885831356049, -0.018084464594721794, 0.03521888703107834, -0.09251534938812256, -0.09628812223672867, -0.1742260754108429, -0.027315903455018997, 0.07491843402385712, -0.1055460125207901, 0.03537944704294205, 0.02749130129814148, -0.022789208218455315, -0.005546318367123604, 0.050164151936769485, 0.0793643593788147, -0.07214412093162537, 0.05033770203590393, 0.0007960144430398941, -0.040488146245479584, -0.05045883357524872, -0.16778185963630676, 0.1655208170413971, -0.016776204109191895], "changes": {"1wk": -9.756095610793878, "1mo": 12.195124965136735}}, {"text": "Cyclacel Pharmaceuticals Third Quarter 2024 Earnings: EPS Beats Expectations editorial-team@simplywallst.com (Simply Wall St) Fri, Nov 15, 2024, 1:06 PM 1 min read In This Article: CYCC +4.50% CYCCP -8.24% Cyclacel Pharmaceuticals ( NASDAQ:CYCC ) Third Quarter 2024 Results Key Financial Results Net loss: US$1.96m (loss narrowed by 68% from 3Q 2023). US$0.18 loss per share (improved from US$7.22 loss in 3Q 2023). NasdaqCM:CYCC Earnings and Revenue History November 15th 2024 All figures shown in the chart above are for the trailing 12 month (TTM) period Cyclacel Pharmaceuticals Earnings Insights Looking ahead, revenue is forecast to grow 83% p.a. on average during the next 3 years, compared to a 22% growth forecast for the Biotechs industry in the US. Performance of the American Biotechs industry. The company's shares are down 7.6% from a week ago. Risk Analysis Before we wrap up, we've discovered 5 warning signs for Cyclacel Pharmaceuticals that you should be aware of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CYCC", "date": "2024-11-15T13:06:53", "sentiment": {"score": -0.6254599820822477, "confidence": 0.6497153639793396, "probabilities": {"positive": 0.024255381897091866, "negative": 0.6497153639793396, "neutral": 0.32602930068969727}}, "embedding": [-0.021548302844166756, 0.006881626322865486, -0.04736143723130226, 0.03538227826356888, 0.020811349153518677, 0.05835966765880585, -0.08587215095758438, 0.22548635303974152, 0.07022983580827713, -0.041429609060287476, -0.14749455451965332, 0.07013244181871414, 0.12285904586315155, 0.02421281859278679, -0.1776382476091385, -0.05301836133003235, -0.013598882593214512, -0.02928743325173855, -0.06744317710399628, 0.05988215655088425, -0.08746114373207092, -0.015319835394620895, 0.019804412499070168, 0.05921286717057228, 0.051624756306409836, 0.035312701016664505, -0.11978311091661453, 0.06852491199970245, -0.172554150223732, -0.06765671074390411, -0.046176373958587646, 0.16072921454906464, 0.1355711668729782, -0.11551886796951294, 0.07802296429872513, 0.08852605521678925, -0.11943146586418152, 0.0578947514295578, 0.14313825964927673, -0.06856387853622437, 0.022264836356043816, -0.0642613023519516, -0.11575408279895782, 0.09192273020744324, 0.020738892257213593, -0.1257500797510147, -0.006168496794998646, 0.0026158676482737064, 0.02819463610649109, -0.01940089650452137, -0.15181313455104828, -0.0938144251704216, 0.04788815230131149, 0.008252117782831192, 0.004832252860069275, 0.0576130747795105, -0.23298680782318115, -0.14602622389793396, 0.03644895553588867, -0.16197679936885834, 0.07723243534564972, 0.047938138246536255, -0.01023387722671032, 0.07079710066318512, 0.06275492161512375, -0.004838844761252403, -0.03615408018231392, 0.08487983047962189, -0.03495766595005989, 0.028604142367839813, 0.005033212713897228, -0.09426675736904144, -0.1108216792345047, 0.0934002473950386, -0.0475214384496212, 0.20048964023590088, 0.18400144577026367, 0.07175873965024948, 0.029717618599534035, -0.15455278754234314, 0.11439622938632965, 0.024220695719122887, -0.10434775799512863, -0.049255989491939545, -0.030654339119791985, 0.003901518415659666, 0.15387946367263794, 0.07773731648921967, 0.015883395448327065, 0.029710659757256508, 0.22497005760669708, 0.06904934346675873, -0.051819074898958206, -0.008084142580628395, 0.03774210065603256, -0.05419163405895233, -0.09067962318658829, -0.08040827512741089, -0.025197211652994156, 0.06439892947673798, 0.2235531359910965, 0.05464683845639229, -0.08295686542987823, -0.11785390228033066, -0.10332883894443512, -0.12860234081745148, 0.0369444340467453, 0.04772802069783211, 0.0027610522229224443, 0.02304195612668991, -0.15771019458770752, 0.06809185445308685, -0.16104649007320404, -0.108416348695755, -0.00479458924382925, 0.098241426050663, -0.018852772191166878, -0.05628073960542679, 0.16302810609340668, -0.03257916867733002, 0.020952513441443443, 0.09176914393901825, -0.023650242015719414, -0.0008661429164931178, 0.006319917738437653, 0.0009539354359731078, -0.14660607278347015, 1.1634610355581105e-32, -0.03716478869318962, 0.0819782018661499, 0.08451060205698013, -0.04392404109239578, -0.026086289435625076, 0.052705924957990646, 0.05609434098005295, -0.08584952354431152, -0.04248747602105141, -0.11359158158302307, -0.23854072391986847, 0.07161834090948105, 0.015579823404550552, -0.062143225222826004, -0.0380832701921463, -0.04850464314222336, -0.015212379395961761, -0.021439213305711746, 0.040605589747428894, -0.08697265386581421, -0.054019369184970856, -0.029222456738352776, -0.0722869336605072, 0.06769637763500214, 0.07149037718772888, -0.030006472021341324, -0.052435629069805145, -0.027112718671560287, -0.038278598338365555, 0.03254719823598862, -0.12529432773590088, 0.0426671989262104, -0.07227759808301926, -0.08685031533241272, 0.013561167754232883, -0.013935547322034836, -0.19481277465820312, -0.06162178888916969, 0.10269609093666077, 0.015147392638027668, -0.1335923671722412, 0.030666707083582878, -0.04407089948654175, -0.04931170120835304, 0.09495333582162857, 0.07974155247211456, -0.10259759426116943, 0.025202706456184387, -0.06884785741567612, -0.09990435838699341, -0.003289218759164214, 0.028627218678593636, -0.14622122049331665, 0.020197371020913124, -0.1130823940038681, 0.0892239585518837, -0.024370646104216576, -0.11361479759216309, 0.023543786257505417, 0.09277746826410294, 0.019093655049800873, 0.24211932718753815, -0.046585794538259506, -0.06046393886208534, -0.20452557504177094, 0.15270785987377167, -0.15753914415836334, 0.08904188126325607, -0.16082634031772614, 0.17595702409744263, -0.03624562919139862, -0.10025656223297119, 0.20226110517978668, 0.042512353509664536, 0.14879059791564941, 0.04885559901595116, -0.0870482325553894, 0.006792018655687571, 0.1335429549217224, 0.053527772426605225, 0.006025843787938356, -0.0049264621920883656, 0.019435612484812737, -0.01914755254983902, -0.036051273345947266, -0.06454746425151825, 0.15411131083965302, -0.042623139917850494, -0.04133505001664162, 0.1546759456396103, -0.006080688908696175, -0.15270066261291504, -0.02666759118437767, 0.21956989169120789, -0.07494194060564041, -1.5121810590895395e-32, -0.05198497697710991, 0.04008907079696655, 0.12965525686740875, -0.07228931784629822, -0.0686928853392601, -0.03340945765376091, -0.017827508971095085, 0.006778485607355833, 0.08892041444778442, -0.06953030079603195, 0.09485922008752823, 0.09206758439540863, -0.042329005897045135, 0.09725594520568848, -0.07673358172178268, 0.023920034989714622, 0.0891658142209053, -0.11414357274770737, -0.053858138620853424, 0.025663860142230988, -0.03538822755217552, 0.0850401371717453, -0.17092707753181458, 0.1451946347951889, -0.020396091043949127, 0.09022065252065659, 0.1565825194120407, 0.09136317670345306, 0.03365419805049896, -0.04700256139039993, -0.07323334366083145, 0.08611936867237091, -0.20937013626098633, 0.12364434450864792, -0.0052887871861457825, 0.0982043594121933, 0.07863075286149979, -0.24574874341487885, 0.031071744859218597, -0.06273198872804642, 0.11750941723585129, 0.09886720031499863, -0.07283290475606918, 0.009936015121638775, 0.07779902219772339, -0.023027274757623672, 0.1292562037706375, -0.05276396498084068, 0.1354156732559204, 0.14316099882125854, 0.09634639322757721, 0.10770732909440994, -0.022678492590785027, 0.0849507674574852, -0.10408953577280045, 0.06365268677473068, 0.05244933441281319, -0.007296302355825901, -0.05342521518468857, 0.029935477301478386, -0.003892485285177827, 0.15511932969093323, -0.10809460282325745, -0.0653262659907341, 0.06219956651329994, -0.0295865535736084, 0.07331439107656479, 0.005591589026153088, 0.03716403990983963, -0.10718832165002823, 0.08096673339605331, -0.02044779434800148, 0.006896068807691336, -0.1538458615541458, 0.015718741342425346, 0.14617551863193512, -0.05756692588329315, -0.11215431243181229, -0.13724802434444427, 0.09551384299993515, 0.03577209264039993, 0.028189821168780327, 0.05186663568019867, 0.022687137126922607, -0.06594223529100418, 0.02803673967719078, 0.034995902329683304, -0.014024891890585423, -0.07937625050544739, -0.042521338909864426, -0.10435638576745987, -0.11501100659370422, -0.07716198265552521, 0.0919625535607338, 0.05865742638707161, -1.0001568284678797e-07, 0.056516412645578384, -0.10897329449653625, 0.0869339108467102, -0.0520121306180954, 0.07623544335365295, -0.05588037520647049, 0.037414487451314926, -0.05114500969648361, 0.04637201875448227, 0.11421576142311096, 0.1132875606417656, 0.05505960062146187, -0.22275714576244354, -0.008648295886814594, -0.1420336812734604, 0.07737817615270615, -0.21290110051631927, 0.0009052582900039852, 0.02353796362876892, -0.1307542473077774, 0.015312287956476212, 0.11696232110261917, -0.08019546419382095, -0.035120148211717606, 0.13190577924251556, -0.1825316697359085, 0.02574199065566063, 0.1093764379620552, -0.04940062761306763, -0.0006984529318287969, 0.09714511781930923, -0.06623823195695877, 0.08857996016740799, 0.00716651463881135, 0.029970314353704453, -0.07700902223587036, 0.1275164633989334, -0.03396124020218849, 0.02286221832036972, 0.13589034974575043, -0.0679326206445694, -0.0026317527517676353, -0.013657723553478718, -0.00739368936046958, -0.06557277590036392, -0.14384981989860535, -0.12909509241580963, 0.02581527829170227, 0.07660811394453049, -0.19289252161979675, 0.126582533121109, -0.048716455698013306, 0.0968579426407814, 0.0698966458439827, 0.11158718168735504, 0.02957144007086754, -0.14317329227924347, -0.03628683090209961, -0.10556325316429138, -0.10496805608272552, -0.08994278311729431, -0.2806977927684784, 0.0703500360250473, 0.1333719938993454], "changes": {"1wk": -5.405408235428679, "1mo": -2.7027000903735274}}, {"text": "Cyclacel Pharmaceuticals Announces Closing of Exercise of Warrants for $2.1 Million Gross Proceeds Cyclacel Fri, Nov 15, 2024, 12:15 AM 5 min read In This Article: CYCC +4.50% CYCCP -8.24% Cyclacel BERKELEY HEIGHTS, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; \"Cyclacel\" or the \"Company\"), a biopharmaceutical company developing innovative cancer medicines, today announced that it closed its previously announced transaction involving the exercise of certain existing warrants to purchase an aggregate of 4,968,945 shares of its common stock having an original exercise price of $1.36 per share, originally issued in May 2024, at a reduced exercise price of $0.415 per share. The resale of the shares of common stock issued upon exercise of the existing warrants is registered pursuant to an effective registration statement on Form S-1 (File No. 333-279157). H.C. Wainwright & Co. acted as the exclusive placement agent for the offering. In consideration for the immediate exercise of the existing warrants for cash, the Company issued new unregistered Series C warrants to purchase up to an aggregate of 9,937,890 shares of common stock and new unregistered Series D warrants to purchase up to 9,937,890 shares of common stock. The new warrants have an exercise price of $0.415 per share and will be exercisable commencing on the effective date of stockholder approval of the issuance of the shares issuable upon the exercise of the new warrants (the \u201cStockholder Approval\u201d). The new Series C warrants have a term of five and one-half years from the Stockholder Approval, and the new Series D warrants have a term of eighteen months from the Stockholder Approval. The gross proceeds from the offering were approximately $2.1 million, prior to deducting placement agent\u2019s fees and other offering expenses payable by the Company. The Company intends to use the net proceeds from the offering for working capital and other general corporate purposes. The new warrants described above were offered in a private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the \u201cSecurities Act\u201d), and/or Regulation D promulgated thereunder and, along with the shares of common stock underlying the new warrants, have not been registered under the Securities Act, or applicable state securities laws. Accordingly, the new warrants and shares of common stock underlying the new warrants may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws. The Company has agreed to file a registration statement with the Securities and Exchange Commission covering the resale of the shares of common stock issuable upon the exercise of the new warrants. Story Continues This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction. About Cyclacel Pharmaceuticals, Inc. Cyclacel is a clinical-stage, biopharmaceutical company developing innovative cancer medicines based on cell cycle, transcriptional regulation and mitosis biology. The transcriptional regulation program is evaluating fadraciclib, a CDK2/9 inhibitor, and the anti-mitotic program plogosertib, a PLK1 inhibitor, in patients with both solid tumors and hematological malignancies. Cyclacel's strategy is to build a diversified biopharmaceutical business based on a pipeline of novel drug candidates addressing oncology and hematology indications. For additional information, please visit www.cyclacel.com. Forward-looking Statements This news release contains certain forward-looking statements that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. Such forward-looking statements include, among other things, statements related to the intended use of proceeds from the offering and the receipt of Stockholder Approval. Factors that may cause actual results to differ materially include market and other conditions, the risk that product candidates that appeared promising in early research and clinical trials do not demonstrate safety and/or efficacy in larger-scale or later clinical trials, trials may have difficulty enrolling,\u00a0Cyclacel\u00a0may not obtain approval to market its product candidates, the risks associated with reliance on outside financing to meet capital requirements, the risks associated with reliance on collaborative partners for further clinical trials, development and commercialization of product candidates and Cyclacel\u2019s ability to regain and maintain compliance with Nasdaq\u2019s continued listing requirements. You are urged to consider statements that include the words \"may,\" \"will,\" \"would,\" \"could,\" \"should,\" \"believes,\" \"estimates,\" \"projects,\" \"potential,\" \"expects,\" \"plans,\" \"anticipates,\" \"intends,\" \"continues,\" \"forecast,\" \"designed,\" \"goal,\" or the negative of those words or other comparable words to be uncertain and forward-looking. For a further list and description of the risks and uncertainties the Company faces, please refer to our most recent Annual Report on Form 10-K and other periodic and other filings we file with the\u00a0Securities and Exchange Commission\u00a0and are available at www.sec.gov . Such forward-looking statements are current only as of the date they are made, and we assume no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. Contacts Company: Paul McBarron, (908) 517-7330, IR@cyclacel.com \u00a9 Copyright 2024 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. The Cyclacel logo and Cyclacel \u00ae are trademarks of Cyclacel Pharmaceuticals, Inc. View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CYCC", "date": "2024-11-15T00:15:00", "sentiment": {"score": 0.017814159393310547, "confidence": 0.035029567778110504, "probabilities": {"positive": 0.035029567778110504, "negative": 0.017215408384799957, "neutral": 0.947754979133606}}, "embedding": [-0.16329354047775269, -0.051663465797901154, 0.02661382220685482, -0.04704786837100983, -0.1913149058818817, 0.0630839541554451, 0.0011293054558336735, 0.1846335530281067, 0.16907170414924622, 0.08292260766029358, 0.07967957854270935, 0.07359585911035538, 0.09077586233615875, -0.05412871390581131, -0.1388925015926361, -0.05755898356437683, -0.024774668738245964, 0.013738101348280907, -0.16496936976909637, 0.14265111088752747, -0.07617054879665375, -0.044029783457517624, -0.009229166433215141, 0.07991378754377365, 0.016084514558315277, 0.034444261342287064, -0.08020798116922379, 0.0720839649438858, -0.12147662043571472, -0.025297384709119797, 0.08940675854682922, 0.1423807144165039, 0.12300557643175125, -0.07167865335941315, 0.14341750741004944, -0.012551311403512955, -0.14040789008140564, 0.024769186973571777, 0.05908585339784622, -0.08315439522266388, -0.03903421759605408, 0.013342360034584999, -0.09290510416030884, 0.12323743849992752, -0.007497443817555904, 0.003826303407549858, -0.06236200034618378, 0.07250691950321198, 0.1101410984992981, -0.003125268965959549, -0.0818701982498169, -0.05014149099588394, -0.09968622773885727, 0.05714702233672142, -0.08321686834096909, 0.012586012482643127, -0.20566856861114502, -0.1112571656703949, 0.017089273780584335, -0.019424734637141228, 0.06648584455251694, 0.04908566549420357, -0.009312979876995087, 0.07720553874969482, 0.030202407389879227, 0.045751314610242844, -0.00904005952179432, -0.03937974572181702, 0.0389191210269928, 0.033630963414907455, 0.05329366773366928, 0.0043562427163124084, -0.10224523395299911, 0.03393925726413727, -0.2027537077665329, 0.13141056895256042, 0.030338820070028305, -0.03969007357954979, -0.0026748524978756905, -0.23111730813980103, 0.010644694790244102, 0.030204501003026962, -0.022483469918370247, -0.1510293334722519, -0.012386706657707691, -0.06627228856086731, 0.08955202996730804, 0.07846245169639587, 0.1951369047164917, -0.04977533221244812, 0.13678210973739624, 0.03306042402982712, -0.12618781626224518, -0.11655613780021667, -0.09666281938552856, -0.044476717710494995, -0.03596668690443039, 0.09517088532447815, 0.02770879864692688, 0.15056660771369934, 0.2066102921962738, 0.03797411173582077, -0.09784867614507675, -0.0786508172750473, -0.07002637535333633, -0.05473068356513977, -0.009246678091585636, -0.01222873292863369, -0.07990540564060211, -0.03270931541919708, -0.13834461569786072, -0.03956881910562515, -0.08365058153867722, -0.05154432728886604, -0.086921826004982, 0.23987597227096558, 0.08352234959602356, 0.0353357270359993, 0.11630165576934814, -0.15700149536132812, 0.1605437994003296, -0.025183510035276413, 0.013389606960117817, -0.06910242140293121, -0.043443404138088226, -0.10545575618743896, -0.13037876784801483, 8.823256189168274e-33, -0.07664026319980621, -0.03696078434586525, 0.026490626856684685, 0.03695381060242653, -0.014787368476390839, 0.019170911982655525, 0.10981245338916779, 0.030119415372610092, -0.10506788641214371, 0.03570931404829025, -0.10197297483682632, 0.01915851980447769, -0.013631745241582394, -0.17525708675384521, -0.08518869429826736, -0.06538435071706772, 0.024120137095451355, 0.07846781611442566, 0.041244152933359146, -0.07806938886642456, 0.05802486464381218, 0.012201767414808273, 0.022261861711740494, 0.1031140685081482, -0.08854612708091736, 0.05380312353372574, -0.04173509031534195, -0.0344756543636322, 0.021152151748538017, 0.00843935739248991, 0.034599483013153076, 0.05638367682695389, 0.002427350729703903, 0.04625566303730011, 0.06231016665697098, 0.01696254312992096, -0.0441199466586113, -0.10591411590576172, 0.22840015590190887, 0.05960512161254883, -0.07050009071826935, -0.00866854377090931, 0.025555642321705818, -0.19243678450584412, -0.05882745608687401, -0.023109888657927513, -0.1659042239189148, 0.12938281893730164, 0.06969490647315979, -0.0008839517831802368, 0.03630877286195755, -0.020940987393260002, -0.1028088629245758, 0.0012417575344443321, -0.08517096936702728, 0.02809184417128563, -0.114421546459198, -0.022875921800732613, -0.01808393932878971, 0.19257858395576477, 0.01950095221400261, 0.19037261605262756, -0.10773420333862305, 0.04132075235247612, -0.18517425656318665, 0.056405745446681976, -0.1375018060207367, -0.06728781759738922, -0.08130118250846863, 0.1792842596769333, 0.013944646343588829, -0.04259548708796501, 0.11162260919809341, -0.008575636893510818, 0.1545112133026123, -0.0749121755361557, 0.07533152401447296, 0.02675708942115307, 0.08796218037605286, 0.05839762091636658, -0.043731674551963806, -0.05580177158117294, -0.04452972859144211, 0.1437959372997284, -0.08993851393461227, -0.0875050500035286, 0.036673083901405334, 0.035730063915252686, -0.0632583498954773, -0.00042221229523420334, 0.019707700237631798, -0.17301462590694427, -0.05675198510289192, 0.1693185567855835, 0.07991336286067963, -9.801061777541024e-33, -0.0009731873869895935, -0.019695136696100235, -0.0034909313544631004, -0.06988196074962616, -0.03876664489507675, 0.03574258089065552, 0.014737170189619064, -0.14538174867630005, -0.04383218288421631, -0.046262457966804504, 0.0012657884508371353, 0.07913652807474136, -0.020478542894124985, 0.04820019751787186, -0.08304647356271744, 0.01128324493765831, 0.11604835093021393, -0.008440434001386166, -0.029040493071079254, 0.10245853662490845, -0.020103078335523605, 0.1428070217370987, 0.022920984774827957, 0.12352046370506287, 0.08334748446941376, 0.08254797756671906, 0.09207890927791595, 0.1763991415500641, 0.07691209018230438, 0.06936362385749817, -0.07047826051712036, -0.058443956077098846, -0.13422463834285736, 0.10041654109954834, 0.012615518644452095, -0.08005768060684204, 0.16444338858127594, -0.09148014336824417, 0.02660452201962471, 0.02114826627075672, 0.07235758006572723, 0.013582093641161919, 0.05460202693939209, 0.13747307658195496, 0.1304563283920288, -0.11823239922523499, 0.06037680059671402, -0.11185555905103683, 0.150747150182724, -0.0024115806445479393, 0.020853282883763313, 0.04293159395456314, 0.008040420711040497, 0.15436069667339325, -0.12061259150505066, 0.2214784026145935, 0.048621729016304016, 0.04361209645867348, 0.008173227310180664, -0.08763483166694641, 0.08726279437541962, 0.14537492394447327, -0.09091964364051819, -0.10925666987895966, 0.1300308108329773, -0.022391755133867264, -0.060736283659935, -0.04186233878135681, -0.05972742289304733, -0.12879683077335358, -0.059532180428504944, -0.23835590481758118, 0.04091373831033707, -0.28087520599365234, 0.04763967543840408, 0.09998636692762375, 0.028872350230813026, -0.18375524878501892, -0.07756567001342773, 0.04044104367494583, -0.04753968492150307, 0.038705967366695404, 0.05275861918926239, 0.06814678013324738, -0.08784565329551697, 0.0134726632386446, 0.06571274995803833, 0.028562214225530624, -0.06674370914697647, 0.021158646792173386, -0.04428844153881073, -0.01826179400086403, 0.12557566165924072, 0.013037377968430519, -0.07628613710403442, -1.0010805340243678e-07, -0.07163862884044647, -0.03094727359712124, 0.00889933668076992, -0.04142453894019127, 0.24213925004005432, -0.10731889307498932, 0.014300468377768993, -0.028449296951293945, 0.02638182044029236, 0.04904491454362869, 0.13794481754302979, 0.05941931903362274, -0.12549757957458496, 0.01959783211350441, -0.15704405307769775, 0.017918137833476067, -0.15129877626895905, 0.03077181987464428, -0.12828096747398376, -0.006430541630834341, -0.10525256395339966, 0.05752474069595337, -0.03217700123786926, -0.0999530702829361, -0.09198153018951416, -0.10239489376544952, 0.08432528376579285, -0.02688804268836975, 0.046463578939437866, 0.07301083207130432, 0.05359204113483429, 0.0034470632672309875, 0.16385674476623535, 0.04398513212800026, -0.024152502417564392, -0.02816208079457283, 0.016604702919721603, 0.11487586051225662, -0.026887202635407448, 0.055060677230358124, -0.062029704451560974, 0.0814918801188469, 0.008672249503433704, 0.13903504610061646, 0.12125496566295624, -0.147331103682518, -0.2887648940086365, -0.07145827263593674, 0.0965801253914833, -0.1709333062171936, 0.08012863993644714, 0.04935155808925629, -0.07283878326416016, 0.03156117722392082, 0.03882674127817154, 0.08196651935577393, -0.05163860321044922, 0.020773498341441154, -0.12529870867729187, -0.00600037258118391, -0.07567106187343597, -0.20182761549949646, 0.09633806347846985, 0.05306454747915268], "changes": {"1wk": -10.256408492959162, "1mo": -7.692300638503319}}, {"text": "Cyclacel Pharmaceuticals Announces Exercise of Warrants for $2.1 Million Gross Proceeds Cyclacel Wed, Nov 13, 2024, 8:22 PM 5 min read In This Article: CYCC +4.50% CYCCP -8.24% Cyclacel BERKELEY HEIGHTS, N.J., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; \"Cyclacel\" or the \"Company\"), a biopharmaceutical company developing innovative cancer medicines, today announced that it has entered into a definitive agreement for the exercise of certain existing warrants to purchase an aggregate of 4,968,945 shares of its common stock having an original exercise price of $1.36 per share, originally issued in May 2024, at a reduced exercise price of $0.415 per share. The resale of the shares of common stock issuable upon exercise of the existing warrants is registered pursuant to an effective registration statement on Form S-1 (File No. 333-279157). H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. In consideration for the immediate exercise of the existing warrants for cash, the Company will issue new unregistered Series C warrants to purchase up to an aggregate of 9,937,890 shares of common stock and new unregistered Series D warrants to purchase up to 9,937,890 shares of common stock. The new warrants will have an exercise price of $0.415 per share and will be exercisable commencing on the effective date of stockholder approval of the issuance of the shares issuable upon the exercise of the new warrants (the \u201cStockholder Approval\u201d). The new Series C warrants have a term of five and one-half years from the Stockholder Approval, and the new Series D warrants will have a term of eighteen months from the Stockholder Approval. The closing of the warrant exercise transaction is expected to occur on or about November 14, 2024, subject to satisfaction of customary closing conditions. The gross proceeds from the offering are expected to be approximately $2.1 million, prior to deducting placement agent\u2019s fees and other offering expenses payable by the Company. The Company intends to use the net proceeds from the offering for working capital and other general corporate purposes. The new warrants described above are being offered in a private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the \u201cSecurities Act\u201d), and/or Regulation D promulgated thereunder and, along with the shares of common stock underlying the new warrants, have not been registered under the Securities Act, or applicable state securities laws. Accordingly, the new warrants and shares of common stock underlying the new warrants may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws. The Company has agreed to file a registration statement with the Securities and Exchange Commission covering the resale of the shares of common stock issuable upon the exercise of the new warrants. Story Continues This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction. About Cyclacel Pharmaceuticals, Inc. Cyclacel is a clinical-stage, biopharmaceutical company developing innovative cancer medicines based on cell cycle, transcriptional regulation and mitosis biology. The transcriptional regulation program is evaluating fadraciclib, a CDK2/9 inhibitor, and the anti-mitotic program plogosertib, a PLK1 inhibitor, in patients with both solid tumors and hematological malignancies. Cyclacel's strategy is to build a diversified biopharmaceutical business based on a pipeline of novel drug candidates addressing oncology and hematology indications. For additional information, please visit www.cyclacel.com. Forward-looking Statements This news release contains certain forward-looking statements that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. Such forward-looking statements include, among other things, statements related to the completion of the offering, the satisfaction of customary closing conditions related to the offering, the intended use of proceeds therefrom and the receipt of Stockholder Approval. Factors that may cause actual results to differ materially include market and other conditions, the risk that product candidates that appeared promising in early research and clinical trials do not demonstrate safety and/or efficacy in larger-scale or later clinical trials, trials may have difficulty enrolling,\u00a0Cyclacel\u00a0may not obtain approval to market its product candidates, the risks associated with reliance on outside financing to meet capital requirements, the risks associated with reliance on collaborative partners for further clinical trials, development and commercialization of product candidates and Cyclacel\u2019s ability to regain and maintain compliance with Nasdaq\u2019s continued listing requirements. You are urged to consider statements that include the words \"may,\" \"will,\" \"would,\" \"could,\" \"should,\" \"believes,\" \"estimates,\" \"projects,\" \"potential,\" \"expects,\" \"plans,\" \"anticipates,\" \"intends,\" \"continues,\" \"forecast,\" \"designed,\" \"goal,\" or the negative of those words or other comparable words to be uncertain and forward-looking. For a further list and description of the risks and uncertainties the Company faces, please refer to our most recent Annual Report on Form 10-K and other periodic and other filings we file with the\u00a0Securities and Exchange Commission\u00a0and are available at www.sec.gov . Such forward-looking statements are current only as of the date they are made, and we assume no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. Contacts Company: Paul McBarron, (908) 517-7330, IR@cyclacel.com \u00a9 Copyright 2024 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. The Cyclacel logo and Cyclacel\u00ae are trademarks of Cyclacel Pharmaceuticals, Inc. View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CYCC", "date": "2024-11-13T20:22:00", "sentiment": {"score": 0.017443591728806496, "confidence": 0.03400207683444023, "probabilities": {"positive": 0.03400207683444023, "negative": 0.016558485105633736, "neutral": 0.9494394659996033}}, "embedding": [-0.1751413643360138, -0.039668843150138855, 0.05107801780104637, -0.06018758565187454, -0.20872607827186584, 0.0664796233177185, 0.006102018058300018, 0.17198136448860168, 0.16290394961833954, 0.07930970191955566, 0.06996849179267883, 0.04945570230484009, 0.07944969832897186, -0.03703535348176956, -0.12889209389686584, -0.048539385199546814, -0.023280609399080276, 0.008918322622776031, -0.17017126083374023, 0.1469404101371765, -0.08919346332550049, -0.06733623892068863, -0.03232486918568611, 0.084538534283638, 0.030782759189605713, 0.02240072563290596, -0.05905561149120331, 0.06813158839941025, -0.12354312837123871, -0.032070182263851166, 0.07997822016477585, 0.12821757793426514, 0.13522402942180634, -0.048014335334300995, 0.1406521201133728, -0.02632245048880577, -0.17271113395690918, 0.020120395347476006, 0.0660666897892952, -0.07927602529525757, -0.050604574382305145, -0.005617803893983364, -0.08313724398612976, 0.11974851787090302, 0.010050651617348194, 0.009837226010859013, -0.0593581348657608, 0.08707527071237564, 0.11211444437503815, -0.0003876443952322006, -0.0785670280456543, -0.061494290828704834, -0.10999952256679535, 0.03755304217338562, -0.1049158126115799, 0.002636052668094635, -0.21508674323558807, -0.11906027793884277, 0.01078372448682785, -0.03541892021894455, 0.07537636160850525, 0.04269922524690628, -0.0191159937530756, 0.08848127722740173, 0.0496087521314621, 0.05377301573753357, 0.020550476387143135, 0.018891677260398865, 0.02480991743505001, 0.0635046437382698, 0.06499138474464417, 0.015265395864844322, -0.12695416808128357, 0.014907686039805412, -0.19619497656822205, 0.1477316915988922, 0.018962854519486427, -0.03707531467080116, 0.012736682780086994, -0.25953319668769836, -0.0072275735437870026, 0.05155882239341736, -0.029221314936876297, -0.19021865725517273, -0.004653109237551689, -0.0958201140165329, 0.08916683495044708, 0.09966409206390381, 0.19947731494903564, -0.07732167094945908, 0.12026368081569672, 0.027491580694913864, -0.102574422955513, -0.10367724299430847, -0.07998980581760406, 0.008060547523200512, -0.04219500347971916, 0.057220615446567535, 0.030095631256699562, 0.15817880630493164, 0.22092515230178833, 0.032161734998226166, -0.09503519535064697, -0.06981255114078522, -0.05678512901067734, -0.0564211942255497, -0.014997761696577072, -0.011463208124041557, -0.06670038402080536, -0.025509871542453766, -0.13681551814079285, -0.044011324644088745, -0.06904864311218262, -0.03173762559890747, -0.10030627250671387, 0.22663450241088867, 0.07468888908624649, 0.033627890050411224, 0.12043435871601105, -0.15468215942382812, 0.1513892412185669, -0.03621899336576462, 0.008201686665415764, -0.07391123473644257, -0.03683316335082054, -0.11868666112422943, -0.13465043902397156, 9.842204079819804e-33, -0.060025885701179504, -0.023248441517353058, 0.032467760145664215, 0.01708460971713066, -0.032277971506118774, 0.039781853556632996, 0.1291102170944214, 0.027784649282693863, -0.1376034915447235, 0.025666140019893646, -0.12245169281959534, 0.0172690749168396, -0.01997482404112816, -0.178061380982399, -0.09474450349807739, -0.07800199836492538, 0.03127412497997284, 0.09553337097167969, 0.04268524795770645, -0.0620933473110199, 0.061856284737586975, -0.025581074878573418, -0.0036785153206437826, 0.11688434332609177, -0.09653113782405853, 0.03446425497531891, -0.0437016636133194, -0.03869335725903511, 0.01851007156074047, 0.01064351201057434, 0.05410362780094147, 0.07765898108482361, -0.00301327439956367, 0.03980289772152901, 0.0549108125269413, 0.008434552699327469, -0.03470839932560921, -0.07847332954406738, 0.21521323919296265, 0.06474831700325012, -0.09905381500720978, -0.007080097682774067, 0.020584719255566597, -0.20658254623413086, -0.038488954305648804, -0.027655214071273804, -0.14540179073810577, 0.12607964873313904, 0.08290547877550125, -0.02670866623520851, 0.0236283577978611, -0.019329678267240524, -0.10134367644786835, -0.008587473072111607, -0.07604742050170898, 0.015493443235754967, -0.1282397359609604, -0.01638050377368927, -0.019150035455822945, 0.1931721568107605, 0.045812468975782394, 0.16245844960212708, -0.11339467763900757, 0.0493612140417099, -0.1720067262649536, 0.08547981083393097, -0.13389094173908234, -0.06361791491508484, -0.06592558324337006, 0.14735156297683716, 0.022900501266121864, -0.06462065875530243, 0.10707519203424454, -0.022039739415049553, 0.14547806978225708, -0.09113844484090805, 0.11977420747280121, 0.03616181015968323, 0.08619914203882217, 0.06151572987437248, -0.08578342199325562, -0.05542178452014923, -0.05419048294425011, 0.1489158570766449, -0.07283630967140198, -0.09429141879081726, 0.05326541140675545, 0.02959383651614189, -0.07788588106632233, 0.005085519514977932, 0.03180955722928047, -0.1567765772342682, -0.053339969366788864, 0.1832706332206726, 0.10209713876247406, -1.048482480089527e-32, 0.004354279488325119, -0.00811871699988842, -0.013214441016316414, -0.06411218643188477, -0.026315927505493164, 0.049592018127441406, 0.017425423488020897, -0.12083537876605988, -0.0355338491499424, -0.033938802778720856, -0.028255760669708252, 0.06574977189302444, -0.02131146565079689, 0.022277172654867172, -0.08768875896930695, -0.003520798869431019, 0.1056201159954071, -0.023060936480760574, 0.0012353076599538326, 0.1321534514427185, -0.03179921954870224, 0.1420271098613739, 0.014066298492252827, 0.1322363317012787, 0.09799620509147644, 0.09716535359621048, 0.08802101016044617, 0.17196860909461975, 0.05253122001886368, 0.08865652978420258, -0.07465521991252899, -0.06816244125366211, -0.15409840643405914, 0.0927577018737793, 0.0010079843923449516, -0.10687077790498734, 0.18563544750213623, -0.06611189991235733, 0.023604590445756912, 0.035780053585767746, 0.08298609405755997, 0.0012991051189601421, 0.052617818117141724, 0.1398993581533432, 0.13891640305519104, -0.13274911046028137, 0.08119669556617737, -0.11709141731262207, 0.15491503477096558, 0.0076867155730724335, 0.04984360933303833, 0.04396981745958328, 0.014335551299154758, 0.15883684158325195, -0.11017149686813354, 0.23767206072807312, 0.034631721675395966, 0.045944757759571075, -0.0034678163938224316, -0.05895664170384407, 0.05949895456433296, 0.1605835258960724, -0.08023709058761597, -0.11282996833324432, 0.13325734436511993, -0.00998850166797638, -0.07823438197374344, -0.021914202719926834, -0.02333102561533451, -0.10996699333190918, -0.07487240433692932, -0.23579460382461548, 0.018559779971837997, -0.29351773858070374, 0.08677589893341064, 0.08939199149608612, 0.05343160405755043, -0.18514081835746765, -0.06345579028129578, 0.043152306228876114, -0.0660872757434845, 0.08360127359628677, 0.05068930983543396, 0.08353668451309204, -0.09619218856096268, -0.00014749355614185333, 0.0766156017780304, 0.03932097554206848, -0.0678434818983078, 0.040260374546051025, -0.03337627649307251, -0.012409434653818607, 0.1461380422115326, -0.01638695038855076, -0.09905016422271729, -1.0024461971624987e-07, -0.07478146255016327, -0.019062239676713943, 0.010239645838737488, -0.048244792968034744, 0.25020870566368103, -0.0955895483493805, 0.026980608701705933, -0.052594948559999466, 0.02716151811182499, 0.038401078432798386, 0.16418570280075073, 0.040901124477386475, -0.12113621085882187, 0.007427041418850422, -0.17420604825019836, 0.006693164352327585, -0.16505976021289825, 0.0388193354010582, -0.16445356607437134, -0.016270583495497704, -0.115889772772789, 0.05536200851202011, -0.018261350691318512, -0.11238796263933182, -0.08944336324930191, -0.09486924111843109, 0.08303084969520569, -0.011961296200752258, 0.03419121727347374, 0.10515809804201126, 0.033490199595689774, -0.006524456664919853, 0.15294240415096283, 0.035613931715488434, -0.03036196529865265, -0.0804288312792778, 0.002691473811864853, 0.10404817759990692, -0.014807742089033127, 0.04339838773012161, -0.06961016356945038, 0.08772189915180206, 0.035164814442396164, 0.13467992842197418, 0.12765002250671387, -0.16868481040000916, -0.2943614423274994, -0.07965302467346191, 0.08975154161453247, -0.1823432445526123, 0.05996226146817207, 0.03591744229197502, -0.05964139476418495, 0.058128636330366135, 0.07201964408159256, 0.09408998489379883, -0.03207283094525337, 0.02042645588517189, -0.1154792532324791, 0.00593219231814146, -0.058825843036174774, -0.21881504356861115, 0.08378542214632034, 0.04384678602218628], "changes": {"1wk": -17.77777453999452, "1mo": -19.99999470180921}}, {"text": "Adherex Technologies Inc. (FENC) Reports Q3 Loss, Misses Revenue Estimates Zacks Equity Research Thu, Nov 7, 2024, 3:25 PM 3 min read Adherex Technologies Inc. (FENC) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to loss of $0.07 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -61.54%. A quarter ago, it was expected that this company would post earnings of $0.06 per share when it actually produced a loss of $0.20, delivering a surprise of -433.33%. Over the last four quarters, the company has not been able to surpass consensus EPS estimates. Adherex Technologies , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $6.97 million for the quarter ended September 2024, missing the Zacks Consensus Estimate by 23.61%. This compares to year-ago revenues of $6.52 million. The company has topped consensus revenue estimates two times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Adherex Technologies shares have lost about 55.9% since the beginning of the year versus the S&P 500's gain of 24.3%. What's Next for Adherex Technologies? While Adherex Technologies has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Adherex Technologies: mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $0.12 on $16.53 million in revenues for the coming quarter and $0.08 on $58.33 million in revenues for the current fiscal year. Story Continues Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Biomedical and Genetics is currently in the top 36% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. Another stock from the same industry, Cyclacel Pharmaceuticals, Inc. (CYCC), has yet to report results for the quarter ended September 2024. This company is expected to post quarterly loss of $0.54 per share in its upcoming report, which represents a year-over-year change of +92.7%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. Cyclacel Pharmaceuticals, Inc.'s revenues are expected to be $0.01 million, down 50% from the year-ago quarter. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Adherex Technologies Inc. (FENC) : Free Stock Analysis Report Cyclacel Pharmaceuticals, Inc. (CYCC) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CYCC", "date": "2024-11-07T15:25:06", "sentiment": {"score": -0.5451195910573006, "confidence": 0.6305994391441345, "probabilities": {"positive": 0.08547984808683395, "negative": 0.6305994391441345, "neutral": 0.2839207649230957}}, "embedding": [-0.14806096255779266, -0.08220400661230087, -0.008713195100426674, 0.12108364701271057, -0.019476909190416336, -0.035059064626693726, 0.008475291542708874, 0.1363258957862854, 0.17378580570220947, 0.10435132682323456, -0.05043196678161621, 0.1421089470386505, 0.07579344511032104, 0.015853922814130783, -0.13497468829154968, 0.011128878220915794, 0.059990253299474716, -0.028564773499965668, -0.032845232635736465, 0.08394574373960495, -0.06704424321651459, 0.009469474665820599, 0.1418677121400833, -0.0007500234059989452, 0.07661844789981842, 0.0866091325879097, -0.10470408201217651, 0.01959957741200924, -0.0830564796924591, -0.12402287125587463, -0.06648091971874237, 0.14715039730072021, 0.0703144520521164, -0.13794709742069244, -0.06511427462100983, -0.05961667373776436, -0.0045125726610422134, 0.044181689620018005, 0.11171776801347733, -0.007317615672945976, -0.05490044504404068, -0.035745348781347275, -0.12311135232448578, -0.005578452255576849, -0.0010605119168758392, -0.20128512382507324, 0.024848200380802155, -0.03371873497962952, 0.004429467022418976, 0.059045661240816116, -0.15120521187782288, -0.18970263004302979, 0.0822860449552536, 0.044310152530670166, -0.12530352175235748, -0.005029568448662758, -0.10388906300067902, -0.0008876258507370949, 0.09249626100063324, 0.021710574626922607, 0.0870891660451889, -0.007540765684098005, 0.013432517647743225, 0.13219788670539856, 0.1973658949136734, 0.04523909464478493, -0.009978226386010647, 0.05687437579035759, -0.10914988815784454, 0.030765363946557045, 0.03566747531294823, -0.018508683890104294, -0.0762447714805603, -0.05809025838971138, -0.05971456319093704, 0.06872516125440598, 0.10911928117275238, 0.056530408561229706, 0.04237128421664238, -0.07205656170845032, 0.047956738620996475, -0.06292831152677536, -0.06984660774469376, -0.02295782044529915, -0.0028143124654889107, 0.06374920904636383, 0.15777821838855743, 0.15986792743206024, 0.00634995149448514, -0.017612284049391747, -0.016326721757650375, 0.015037668868899345, -0.020973846316337585, -0.0362362377345562, 0.1190740242600441, -0.025623338297009468, -0.0037739351391792297, -0.044030409306287766, 0.06337065994739532, 0.040877457708120346, 0.13581350445747375, 0.1606132537126541, -0.08343327790498734, -0.055738262832164764, -0.055048149079084396, -0.16207373142242432, 0.031111788004636765, -0.03616833686828613, 0.035280972719192505, 0.08079379796981812, -0.06653814762830734, 0.06188128888607025, -0.21473471820354462, -0.059107713401317596, -0.10267922282218933, 0.045672304928302765, -0.032049067318439484, 0.08763450384140015, 0.19606027007102966, 0.05740119516849518, 0.08231872320175171, 0.08762770891189575, -0.015214700251817703, 0.06735529005527496, 0.032264888286590576, 0.0853549987077713, -0.14647045731544495, 6.72076846265547e-33, 2.1729618310928345e-05, 0.12551835179328918, -0.07776622474193573, -0.030609194189310074, -0.03258618712425232, -0.024542365223169327, 0.06417708098888397, -0.08626958727836609, -0.04885143041610718, -0.09313555061817169, -0.14856433868408203, 0.18930071592330933, 0.0024812109768390656, -0.061221033334732056, 0.10078401863574982, -0.1700076013803482, -0.038260120898485184, 0.048954129219055176, 0.014766073785722256, 0.007910188287496567, 0.09331698715686798, -0.04990898817777634, -0.029145337641239166, 0.039371829479932785, 0.05658527463674545, -0.030449263751506805, -0.10530884563922882, 0.13547983765602112, -0.13692018389701843, 0.005440389271825552, -0.015687409788370132, 0.05983272194862366, 0.07289176434278488, -0.1786756068468094, -0.03030272386968136, 0.013407956808805466, -0.012999413534998894, -0.07944586127996445, 0.11484409868717194, -0.025879941880702972, -0.08033344149589539, 0.10293477773666382, -0.08279194682836533, -0.21884551644325256, 0.00863213837146759, -0.051871731877326965, -0.004761265590786934, 0.01150993537157774, 0.02563832886517048, -0.06388528645038605, -0.01970648020505905, 0.05005171149969101, -0.05085583031177521, -0.09526676684617996, -0.028566401451826096, 0.02431238442659378, -0.054441675543785095, -0.15251314640045166, -0.008326297625899315, 0.16077962517738342, 0.08265681564807892, 0.21831384301185608, 0.03500707447528839, -0.030452081933617592, -0.18527022004127502, 0.2411247342824936, 0.04691563546657562, 0.14704608917236328, -0.038401201367378235, 0.2600920796394348, -0.051836129277944565, -0.012119466438889503, 0.0501273088157177, -0.08957382291555405, 0.17807038128376007, -0.05265054851770401, -0.10041850805282593, -0.0400892049074173, 0.10391350835561752, 0.007788233458995819, 0.030689271166920662, -0.057465918362140656, -0.028669066727161407, -0.023900102823972702, 0.023934297263622284, -0.056790515780448914, 0.005871062632650137, 0.15959212183952332, -0.03348056226968765, 0.01243581622838974, 0.06517738103866577, -0.13792380690574646, -0.06808634102344513, 0.1857747882604599, -0.054413311183452606, -7.590577711598329e-33, -0.08962070941925049, 0.0179145410656929, 0.004332748241722584, 0.040113262832164764, -0.11988003551959991, -0.03553393483161926, 0.10499079525470734, 0.05471813306212425, 0.01637885719537735, -0.058784618973731995, 0.05602407455444336, 0.11060889065265656, -0.13176865875720978, 0.09756246209144592, -0.13287261128425598, -0.04325093701481819, 0.03308386728167534, -0.16646318137645721, 0.06303741037845612, -0.0797962099313736, 0.083399698138237, 0.10612879693508148, -0.04329225420951843, 0.13846498727798462, -0.01438383013010025, 0.07759484648704529, 0.024395767599344254, 0.09809278696775436, -0.02133515477180481, -0.06472601741552353, -0.034750744700431824, -0.11898173391819, -0.1488805115222931, 0.02988816611468792, 0.03133672475814819, -0.04136204347014427, -0.049247872084379196, -0.0546206533908844, -0.016253963112831116, -0.10010658204555511, 0.1495186984539032, 0.004620200023055077, -0.01130761206150055, -0.01653144508600235, 0.08049976825714111, -0.023776687681674957, -0.01840023696422577, 0.01683161035180092, 0.20986321568489075, 0.07804617285728455, 0.01062855776399374, 0.01809632033109665, -0.0019194874912500381, 0.1052522212266922, -0.1443270742893219, 0.0675632655620575, -0.0453806035220623, 0.0006115548312664032, -0.10346462577581406, 0.010009187273681164, 0.021487176418304443, 0.14964662492275238, 0.04527345299720764, 0.08998313546180725, 0.07028841972351074, 0.025354687124490738, 0.00802125595510006, 0.034678615629673004, -0.056784357875585556, -0.03918641805648804, 0.016475249081850052, -0.050306711345911026, 0.03239775821566582, -0.16405411064624786, 0.03464231640100479, 0.17508260905742645, -0.06030205637216568, -0.14375847578048706, -0.11299611628055573, 0.045057401061058044, 0.07674506306648254, 0.07534347474575043, 0.02972501516342163, -0.003472407115623355, -0.10830721259117126, 0.16636401414871216, -0.01565193012356758, -0.04390297457575798, -0.002519071102142334, -0.04538333788514137, -0.049367472529411316, -0.1601639986038208, -0.10040891915559769, -0.0601845346391201, -0.018045244738459587, -9.976371728726008e-08, 0.0027533071115612984, -0.03231509029865265, 0.06564625352621078, -0.029654014855623245, 0.06897655129432678, -0.054092664271593094, 0.057592324912548065, -0.1145886778831482, 0.09768535196781158, 0.03537029027938843, 0.05930541455745697, 0.0385175496339798, -0.16243043541908264, 0.04358451068401337, -0.11264457553625107, -0.0007742270827293396, -0.14542829990386963, 0.012290221638977528, -0.0075031304731965065, -0.17070770263671875, -0.040709249675273895, 0.021008271723985672, 0.15737615525722504, -0.07518056035041809, 0.10670523345470428, -0.06942036002874374, -0.12601539492607117, 0.02974921092391014, 0.045842401683330536, 0.018419833853840828, 0.027946390211582184, -0.08499981462955475, 0.10044609010219574, 0.04768994450569153, -0.03985542058944702, -0.09252733737230301, 0.15103232860565186, 0.08684428036212921, 0.024292774498462677, 0.17897993326187134, 0.013622831553220749, -0.02766718901693821, 0.07652357220649719, -0.002597631886601448, -0.06683138012886047, -0.12702250480651855, -0.18124395608901978, -0.001591986045241356, 0.03844883292913437, -0.2362689971923828, 0.14559879899024963, -0.09268365800380707, -0.026355497539043427, 0.05762224271893501, 0.0700782984495163, -0.054039690643548965, -0.14592935144901276, 0.01218155212700367, -0.1686665266752243, -0.008210960775613785, 0.05431800335645676, -0.2816237807273865, 0.11183539777994156, 0.16623809933662415], "changes": {"1wk": 4.6511582776364895, "1mo": -11.627909555636291}}]